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ABSTRACT
Multidimensional ion mobility (IM) and mass spectrometry separations have been
applied successfully to the analysis of a wide range of analytes and demonstrate
potential as a selective and high throughput analytical technique.
The direct analysis of pharmaceutical formulations from non-bonded reversed-phase
thin layer chromatography (RP-TLC) plates by desorption electrospray ionisation
(DESI) combined with drift tube ion mobility-mass spectrometry (IM-MS) has been
investigated.  The detection of active pharmaceutical ingredients is demonstrated
with, and without, chromatographic separation of the active ingredients and
formulation excipients.  Varying the solvent composition of the DESI spray using a
gradient allows selective desorption of pharmaceutical ingredients from the surface of
the RP-TLC plate.
The potential of IM-MS in combination with high performance liquid
chromatography (LC) for the metabonomic analysis of rat urine is reported. The
approach allowed the acquisition of nested data sets, with mass spectra acquired at
regular intervals during each IM separation and several IM spectra acquired during
the elution of an LC peak. The application of LC combined with field asymmetric
waveform ion mobility spectrometry (FAIMS) and ion trap mass spectrometry to a
metabonomic study of rat urine, with subsequent data mining by artificial neural
networks, allowed discrimination between young and old rats on the basis of LC-
FAIMS-MS profiles.
The application of IM-MS to real-time reaction monitoring has also been investigated.
Real-time reaction monitoring was carried out over a period of several hours, with the
reaction mixture sampled and analysed at intervals of several minutes. Results
indicate that spectral quality is improved when employing IM-MS, compared to mass
spectrometry alone, as the complexity of the reaction mixture increases with time. The
combined IM-MS approach has potential as a rapid and selective technique to aid
pharmaceutical process control and for the elucidation of reaction mechanism.
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CHAPTER ONE
Introduction
11.1 Ion mobility spectrometry
Objects suspended in a gas or liquid medium experience spontaneous diffusion due to
Brownian motion at finite temperature. With no other forces exerted the diffusion has
no preferred direction, however when an external force is applied (electrical, magnetic
or gravitational) an object will move along its vector with a speed controlled by the
characteristic known as mobility.1 The application of an electric field creates a
Coulomb force which is exerted onto charged particles causing them to move along
field lines, towards increasing potential. Both the diffusion and mobility properties of
an ion are dependant upon the nature of the ion. The study of ions in an electric field
is termed ion mobility spectrometry (IMS). IMS is a gas phase electrophoretic
technique, first introduced in 1970 by Karasek2 under the name plasma
chromatography, IMS has since developed considerably over the last decade and now
branches into two subfields; drift tube ion mobility spectrometry (IMS), where a
constant electric field is applied to a drift tube and methods are based upon absolute
ion transport properties measured using a time-independent electric field, and field
asymmetric waveform ion mobility spectrometry (FAIMS), or differential mobility
spectrometry (DMS) where a change in ion transport properties is a function of a
time-dependent electric field.
IMS allows analytes to be distinguished on the basis of their ion mobility defined by
their reduced mass, charge and collision cross section (i.e., size and shape).3 Ion
mobility is determined by the velocity of an ion under the influence of the electric
field gradient and in the presence of a buffer gas, measured using a drift tube.  Ion
mobility is therefore characteristic of the analyte and the buffer gas, and hence can
provide a means for the detection and identification of single component ions within a
2mixture. The electric field accelerates ions, while collisions with the buffer gas
decelerate them, leading to a constant drift velocity.4  IMS allows for the study of a
wide range of chemical species, from aggregates of carbon and silicon clusters
through to studies of volatile and semi-volatile compounds, biomolecules and
synthetic polymers. 3,5,6,7
1.1.1 Theoretical principles of ion mobility spectrometry
Free molecular diffusion is governed by Fick’s law of diffusion:
JM = -D N Equation 1.1
Where JM represents the number of molecules flowing through a unit area per unit
time, N is the concentration gradient and D the diffusion coefficient which is a
molecular characteristic. A molecule will diffuse differently in different media and so
D is a property of both the diffusing molecules and the media. The velocity of the
diffuse flow, vD, is proportional to D:
vD = - (D/N) N Equation 1.2
Where N is the number density of the gas (the number of molecules per unit volume)
for diffusion in gases, D is determined by:
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Where kB is the Boltzmann constant, T is the gas temperature and μ = (Mm/m+M) is
the reduced mass of the diffusing ion (M) and the drift gas molecule (m).  The
quantity Ω is the collision integral of both the diffusing molecule and the diffusing
media molecule and is termed the collision cross section. Of the variables acting upon
a diffusing molecule Ω is the only variable that depends on the structure of the gas
molecule and the diffusing molecule and therefore unknown molecules can be
characterised based upon measuring the speed of diffusion in a known gas at standard
temperature and pressure and is the basis for ion mobility spectrometry. When a
coulombic force is applied, analyte ions reach a terminal velocity v or the drift
velocity, in IMS different species have different drift velocities depending on their
ions mobility K. 1
Ion mobility spectrometry (IMS), formerly known as plasma chromatography,2 is
based on determining the drift velocities (υd) attained by ionised sample molecules in
the weak electric field of a drift tube containing a gas.  Therefore, ions have to be
formed from sample molecules to measure ion mobilities.8  The drift velocity of an
ion is described by:
υd = KE Equation 1.4
Where υd is the ion drift velocity (cm s-1), K the mobility of an ion (cm2 V-1 S-1) and E
is the electric field strength (V cm-1).
4Ion mobility is further influenced by the operational parameters as well as by the
structural features of the ions, described by the Mason-Schamp equation:
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Where z is the charge on the ion, N the density of drift gas molecules, μ = (m
xM)/(m+M) the reduced mass of the ion (m) and drift gas molecule (M), k the
Boltzmann constant, T the temperature and Ω is the average ionic collision cross-
section. Ω includes structural parameters (size and shape)4.  The mobility of an ion at a
given temperature and buffer gas pressure is therefore determined by the mass, charge
and, most importantly, the collision cross section of the ion.  This relationship only
holds true at the low field limit, where the ratio of E/N is ≤ 2 Td, (where 1Td
(Townsend) = 10-17 C cm2).  At higher values of E/N the mobility is no longer
constant but becomes field dependant, which is the main principle of FAIMS or DMS
as described in Section 1.3.9 Ions in this regime effectiviely have no inertia and hence
mobility of an ion will stop if the field is switched off, ions can be further decelerated
by collisions with the buffer gas molecules with the velocity loss being dependant
upon the m/M ratio and hence velocity is a function of the reduced mass of drift gas
molecules. The acceleration of an ion between braking events or collisions is
proportional to E and their frequency is proportional to N. 1 Hence, V is proportional
to E/N and K is proportional to K=v/E or 1/N. The absolute mobility scale enabling
comparisons between IMS data at different N is attainable by calculating reduced
mobilities.  Reduced mobility (K0) is the ion mobility corrected to standard
5conditions of temperature (T in Kelvin) and pressure (pb in Torr), as an increase in
temperature, or a decrease in pressure, causes ions to travel faster and hence increase
ion mobilities:
K0 = K(273/T) (pb/760)                           Equation 1.6
Ions in gases diffuse regardless of the presence of an electric field described
previously and governed by Brownian motion and hence resolution in IMS is limited
mostly by diffusion of the ion packets along the drift tube. Ion packets placed in a
uniform electric field steadily broaden while drifting along E, the diffusion at low
field limits is isotropic with packets which are initially spherical diffusing equally in
all directions and thus remain spherical. Non spherical packets though initially retain
their shape become increasingly spherical as they drift along E. 1 Diffusion is a
critical parameter in IMS in regards to resolution, if two ion packets diffuse and
overlap then resolution of the two species is not attainable. The resolution (R) is
therefore defined by the intensities of the peaks relative to the baseline:
 
 BA
AB
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tdtdR 

2
                                        Equation 1.7
6And is defined through the full width at half maximum (FWHM) of peak:
2/1w
tdR                                               Equation 1.8
The resolving power in conventional IMS depends on the electric field strength, gas
temperature and pressure, ion charge state, drift tube length and the ion injection gate
width. The non-zero width of ion packets at the start of IMS separations and
broadening mechanisms such as coulomb repulsion, diffusion broadening and also
field heterogeneity, capacitive coupling between approaching ions and the detector
and ion molecule reactions within the drift region all reduce resolution in IMS
separations. Improvements in resolution have been investigated by extending the
separation time of the analysis employing gas flows in addition to electric fields.10 In
order to increase resolving power it is necessary to increase the voltage across the
drift tube. However, it is desirable to keep the ions within the low field limit, low
E/N, where the mobility is independent of the drift field, E. 11  At high fields the
mobility depends on the drift voltage and alignment of the drifting ions may occur.
To overcome this problem and in order to increase the voltage across the drift tube it
is necessary to also increase the buffer gas pressure. Temperature effects resolution in
IMS and the resolving power (Rp) is inversely proportional to the square root of the
drift gas temperature or resolving power decreases when the temperature is increased.
By reducing the overall temperature the diffusion limit can be reduced, however at
extremely low temperatures an increase in ion clustering with water is observed
leading to a decreases in Rp. Cases of increasing resolution with increasing
temperature have also been reported. The increase or decrease in resolution at
7elevated temperatures has been attributed to the changes in separation factor (α)
which is governed by the different hydration and clustering tendency of ions.12
Temperature reduces resolving power but can increase α – depending on hydration
tendencies of the analyte ions. An increase in de-clustering reduces ion size and
hence reduces collisions and Ω of the ion, leading to the potential shift of the ion drift
time which results in the possibility of changing the selectivity of an ion.
Increasing the electric field strength results in relatively higher resolution whereby
diffusion theory predicts that IMS resolving power increases with the square root of
the voltage applied across the drift tube. For example Clemmer et al.13  obtained a
resolving power of 172 for fullerene by increasing the voltage across the drift tube (10
000V) by developing a new high resolution IMS apparatus. However, a consequence
of high electric field strength is that the drift gas pressure must be increased
proportionally to maintain a low E/N ratio also electrical breakdown within gases can
occur at high electric field strengths which caps the maximum E attainable. However,
higher polarisable gases can withstand higher voltages before electrical breakdown
occurs and hence can extend the value of E which can be applied.  The ion injection
gate width is an important factor in relation to IMS resolution, with longer pulse
widths resulting in peak broadening at the start of the IMS separation and a decrease
in resolution. The width of the initial ion packet also determines the shape and width
of an IM peak whilst also preventing diffusion of neutral species into the drift region.
Figure 1.1 displays the effects of initial ion pulse width on resolution at different
pressures. It can be seen that resolution decreases as the gate width increases.14
8Figure 1.1. Predicted and measured resolving power with different gate widths at
various pressures. 14
At zero pressure resolution is equal to zero. Increasing pressure has no effect on
separation factors however, increasing pressure increases resolution.   The decrease in
resolution at low pressures can be compensated by shortening the ion pulse width
since reducing pressure results in a higher ion current (E/N). Resolving power
increases with pressure however it cannot exceed a certain value which is termed the
diffusion limited resolving power. Tabrizchi et al. 14 investigated the effects of
pressure in IMS and showed that reducing pressure has no effect on separation factors
but decreases the resolving power and resolution.
91.1.2 IMS instrumentation
The basic components of an IMS consist of a sample inlet system, an ionisation
region, a reaction region (for 63Ni and CI ionisation processes), an ion gate, a drift
region and an ion collector.  Figure 1.2 illustrates these components in a conventional
stacked ring drift tube design. Sample product ions are formed and directed toward
the drift region by an applied electric field. A narrow pulse of ions is injected into the
drift region using an ion shutter grid.  In the drift region, ions of different identities
are separated based upon, charge, mass and collision cross section. The analytical
signal is obtained when ions strike a conducting plate and the resulting current
amplified.15
Figure 1.2. Schematic diagram of an ion mobility spectrometer taken from reference3
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1.1.2.1 Sample introduction and ionisation
Ions may be generated by numerous ionisation techniques but most commonly
externally using electrospray ionisation (ESI)16 or within the ionisation region of the
IMS drift cell via atmospheric pressure chemical ionisation (APCI) using a 63Ni
source. 17   On entering the drift region ions are subjected to a uniform weak electric
field, which accelerates them towards a detector situated at the end of the drift region.
A buffer gas is also present within the drift cell which is held at a constant pressure,
typically 1-760 Torr2.  Ions passing through the drift region experience collisions with
the buffer gas molecules impeding their progression towards the detector.  Ions with
larger collision cross sections (Ω) experience more collisions with the buffer gas
molecules compared to those with smaller collision cross sections and, therefore take
longer to transverse the drift tube.  As discussed previously collision cross section
includes size and shape and hence separation of ions differing in size and shape (not
necessarily mass).
Numerous sample introduction techniques have been developed and are employed in
IMS.  One method, described by Karpas18, involved the adsorption of sample vapour
onto a nickel wire.  The wire was then inserted, through a septum into the heated
ionisation region. This heated region allows the adsorbed sample to volatilise from
the wire’s surface and be ionised by the 63Ni source.  Further methods of sample
introduction include headspace analysis,19 diffusion tubes,20 permeation tubes,21
membrane inlet, 22,23 syringe injection,24 and laser desorption/ablation.25
The coupling of chromatography with IMS has also been described,26,27,28,29 providing
an additional separation.  IMS was first evaluated as a detector for liquid
11
chromatography (LC) in 197330.  The sample was introduced with the moving wire
technique described above by Karpas.18  Spectra were successfully obtained for
halogenated benzenes, DDT, Endrin, and Dieldrin.  Spectral collection times averaged
two minutes, though no chromatograms were shown, eventually electrospray probes
(described in section 1.4.1.1) were developed over time in order to allow successful
coupling.31  Gas chromatography (GC) however, proved to be a more attainable
coupling strategy with IMS. Sample analytes are already within the gas-phase and
sample sizes are considerably smaller than for LC.  In hyphenated GC-IM the
capillary column is inserted into the ionisation region allowing the eluent to be
directly ionised within its own carrier gas.32
1.1.2.2 The drift region
Once sample ions have been generated they enter the drift region of the IMS cell
where separation can occur (see Figure 1.2).  Ions may either be gated into the drift
region electronically or pulsed in by some other means.  In both cases, a trigger is
required to synchronise the detector with the entry of the ions allowing accurate drift
times to be recorded.  A typical ion gate, or shutter grid as employed in atmospheric
pressure IMS consists of a series of parallel wires held at a potential to prevent entry
of the ions into the drift region.  Potential changes across the wires to match that of
the drift field, opens the gate, allowing the ions to enter the drift region.  The two
main shutter grids employed are the Tyndall gate33 and the Bradbury/Neilson gate.34
12
The Tyndall gate33 consists of two grids separated by <1mm placed across the
entrance of the drift tube.  When a voltage is applied across the two grids the gate is
closed the closed grid also attracts the ions which are neutralised upon impact.
The Bradbury/Neilson gate34  is composed of a single shutter grid in which the shutter
grid consisting of alternate wires is held at opposite polarity to one another.  The gate
is opened when an applied voltage to all the wires equals that of the drift field.
Once the ions have been gated into the drift region, they experience a uniformed
electric field gradient created by a series of metal drift rings (Figure 1.2).  Each drift
ring is connected to the next by a resistor, which acts as a voltage divider.  When a
voltage is applied to the first and last drift ring in the cell, the potential difference
between these voltages is spread evenly across the whole stack of drift rings creating a
constant field gradient.  The strength of the field gradient varies between instruments,
but is typically in the range of 1-500 Vcm-1.
1.1.2.3 The drift gas
The common drift gases employed in IMS are nitrogen and control air, other less
commonly used gases includes helium,35 argon36 and carbon dioxide.27  The use of
different drift gases and their effects on ion mobility have been well documented.37,38
Ions have been found to travel faster in the lighter gases with lower polarisabilities
such as helium.37 Helium also proves valuable in the measurement of collision cross
sections in the gas phase. Due to the low polarisability of helium, molecular
13
modelling and the associated theoretical calculations become simplified.  A loss in
sensitivity with heavier gases has also been reported primarily due to the longer
periods of time the ions spend in the drift region resulting in ion scattering. However,
resolving power has been found to increase due to the ions travelling more slowly.37
The separation of two analytes is dependant upon the separation factor (α) which is
described by:
α=K1/K2 Equation 1.9
Where K1is the mobility of the faster moving ion and K2 is the mobility of the more
slowly moving ion. Therefore, a separation factor of 1 is indicative that two ions have
the same drift velocity and hence are not resolved.39  Changing drift gas composition,
temperature or pressure can alter the mobility of ions and in turn change the
separation factor. Addition of a chiral modifier to the drift gas has also been
investigated40 to separate atenolol enantiomers. The chiral reagent was studied
employing (s)-(+)-2-butanol to demonstrate enantiomeric separations of serine,
methionine, theronine, glucose, penicillamine, valinol, phenylalanine and tryptophan
from their respective racemic mixtures.  The versatility of using different buffer gases
or buffer gas modified by the addition of volatile compounds can affect the interaction
of the ion with the buffer gas. The exploration of crown ethers and
polyethyleneglycol as shift reagents has been carried out. In this approach crown ether
14
is added to the sample to form a complex that is electrosprayed into the gas phase.
The resulting complex has a different mobility than the original analyte ion.41,42
1.1.2.4 The aperture grid
In order to maintain spectral resolution an aperture grid must be placed approximately
1mm in front of the ion collector. The grid design is similar to a Bradbery/Neilson ion
gate. A voltage is applied to the aperture grid to maintain a drift field near the
collector. The function of this grid is to capacitively decouple the collector from the
approaching ion swarm, without the grid the ion swarm is felt coulombicly by the
collector several millimetres prior to its actual arrival resulting in broadening of the
ion peaks. Increase in sensitivity of up to 2.5 times has been described.43
1.2 Applications of IMS
IMS has several strengths that enhance its suitability as an analytical technique.
Firstly, it has a selectivity factor based on ion mobility that allows ions to be
distinguished by collision cross section. Secondly, it is an extremely sensitive
technique with sub-parts-per-billion or picogram detection limits for many
compounds. Thirdly, IMS has continuous real-time monitoring capabilities and,
fourthly, the system can be easily automated. Due to these advantages use of IMS has
increased during the past decade and has become a widely used analytical method,
with more than 50,000 stand-alone ion mobility spectrometers currently employed
throughout the world for the detection of explosives, drugs and chemical warfare
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agents.44 With the development of electrospray45 as an ion source for IMS
applications have expanded from those limited to vapour-phase samples. IMS when
coupled to MS offers additional data not possible from MS alone.  Separation of
isomers, isobars and conformers; reduction in chemical noise and measurement of ion
size are possible.
IMS was first coupled to a gas chromatograph in 197246. The experiment was
designed to enable comparison of both a flame ionization detector (FID) and an IMS
detector. FID response and IMS spectra were recorded and compared from the gas
chromatographic analysis of musk ambrette. GC–IMS was further used in 197647 for
the determination of part-per-million levels of sec-butyl chlorodiphenyl oxides in
biological tissues. IMS was demonstrated to be as a selective and non-selective
detector for GC in another report by Baim et al. who analysed terpenes from orange
extracts by monitoring responses for all product ions having drift times between
specific intervals.48 Recently techniques that utilize a multi-capillary column in
combination with IMS equipped with a radioactive and UV ionization sources have
been developed for the determination of MTBE and BTX in gaseous and aqueous
matrices,49 rapid on-site detection of ground and surface water contaminants,50
chemical warfare detection,32 detection of health relevant analytes from surfaces51 and
detection of volatile organic metabolites in human breath.52 IMS was first evaluated
as a detector for liquid chromatography in 1973 as previously stated. Since then the
application of IMS coupled with LC has emerged as a powerful analytical technique
coinciding with the development of electrospray ionisation (197253) as a sample
ionisation source for ion mobility spectrometry. Although this work utilised two
separation steps, it did not make full use of both dimensions of separation because
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limitations in electronics required that at least one dimension of the system be
operated in a scanning rather than dispersive mode.54
In the late 1990s advances in electronics and data acquisition systems enabled the
development of the first multiply dispersive ion mobility-mass spectrometry (IM-MS)
method, with IMS coupled to time-of-flight MS.55   IMS has since been interfaced to a
variety of mass spectrometers including, time-of-flight,56 quadrupole,57 ion-trap,58
ion-cyclotron59 and magnetic sector mass spectrometers.60 Ion mobility cells can also
be interfaced to other ion mobility cells producing IMSn type analysis.61 Early stand
alone IMS investigations were conducted by McDaniel in low field drift cells to study
the ion mobilities and ion molecule reactions in gases.62 Throughout the 1970s and
1980s ion mobility-mass spectrometry was dominated by the use of MS to identify
mobility selected ions from ion mobility spectrometers. Development of modern
instruments to investigate ion structure was investigated by Jarrod et al.63 and Kemper
and Bowers.64 While initial investigations focused on the studies of ion neutral
reactions of ion clusters, IMS is now employed to study the gas-phase structures of a
wide variety of molecules and application areas. IMS has since been applied to the
study of alkanes, alkenes and cycloalkanes,65 the detection of biogenic amines in food
products,66 the detection of drugs from hair,67 identification of structural motifs of
DNA,68 the determination of ammonia,69 the detection of explosive,70 for use within
the pharmaceutical industry,71 the detection of pesticides72 and environmental soil
contaminants.73
The coupling of IMS to MS afforded greater analytical power through the added
dimension of mobility combined with mass measurement. One unique feature of IM-
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MS spectra is the mass-mobility correlation observed for classes of ions with spectra
plotted with mass as a function of drift time.44 One practical advantage of employing
IMS in combination with mass spectral analysis is the ability to separate multiply
charged ions, as seen in the experiments conducted by Clemmer et al. for protein
digest, whereby a clear separation of charge state was observed.74  Another advantage
of combined IM-MS is that fragmentation of a mobility separated ion can be
achieved. The application of IM-MS is a growing field with a large number of
application areas. The study of proteins75 and amino acids has been reported,76 as well
as carbohydrates, lipids, nucleotides and other bio-molecules,77,78,79 chemical warfare
degradation products,80 drugs of abuse,81 hydrocarbons82, halogenated compounds83
and proteome profiling84.
The separation of small molecules in complex mixtures is an area where IM-MS
offers advantages over MS alone, primarily the combination of IM-MS offers a rapid
method for the analysis of small molecules in which isobars may by separated in
mobility space before mass analysis. Biological process and samples typically contain
a complex matrix making it difficult to detect the many components present. IMS
shows potential to enhance selectivity and detect as many sample components as
possible. The detection of bacteria was achieved by Nicholson et al. for food safety
purposes in 1995.85 In 2005 Baumbach and co workers described the detection of
human metabolites using multi-capillary columns coupled to IMS to gain information
about different metabolic processes of the body.86 During this study it was shown that
volatile compounds could potentially carry important information about the health
status of humans. The metabolic profiling of E.coli87 by IMS highlighted the
advantages of employing IMS compared to MS alone, in that it was not essential for
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the metabolite to be volatile whilst employing ESI, separations were faster, and the
study showed that sensitivity was sufficient to monitor 500 metabolites at the μM
level. Overall this study showed the promising nature of employing IM-MS for
metabonomic studies.
As IM-MS instruments become more commercially available the mobility advantage
in mass analysis will continue to grow, developments in multidimensional IMS, novel
interface technologies and ionisation sources may lead to enhanced sensitivity,
quantification, resolving power and separation selectivity. This in turn will lead to the
increased detection and separation of complex samples.
1.3 Field asymmetric waveform ion mobility spectrometry (FAIMS)
Studies have shown that FAIMS can separates isobaric ions88 including
diastereoisomers,89 separate isomers, reduce background signals by isolating ions of
interest and simplifying spectra of complex mixtures by dividing the mixture into a
series of simpler subsets of ions.90 Applications ranging from quantitative analysis of
inorganic and organometallic compounds, to studies of the conformers of intact
proteins, have been reported 91 (Table 1.1).
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If the ratio of electric field strength (E) to buffer gas number density (N) exceeds the
low-field limit (E/N is ≤ 2 Td), the mobility of an ion, K, is no longer constant
(Section 1.1.1) and the gas-phase mobility of the ion becomes dependant upon electric
field strength:
K(E) = K(0) (1+a (E/N)2+ b(E/N)4 + c(E/N)6+……      Equation 1.10
In a typical FAIMS regime the terms up to b(E/N)4 generally represent K(E) with
sufficient accuracy.  Depending on the relative values of a and b coefficients, K(E)
may increase, decrease, or first increase and then decrease, with corresponding ions
classified as types A/C, and B respectively (Figure 1.3). 92 These designations are
not absolute but are dependant on the buffer gas employed for example; A type
behaviour in one gas may become C type in another.
Figure 1.3 Schematic of three possible examples of dependence of ion mobility on
electric field strength 93
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Resolution and sensitivity within FAIMS is also somewhat buffer gas dependant, and
using binary and ternary mixtures is often better than that with any individual gas
component. 94 The alpha function in Equation 1.10 describes how the mobility of an
ion varies with increasing electrical field strength, and is independent of both the
instrumentation and the applied waveform. However, the exact composition of the
buffer gas is required as buffer gas composition can alter the nature of the ion neutral
clusters.  Positive alpha values are indicative of small ions forming adducts with water
and other neutrals at low electric fields (-CV) and negative alpha values are indicative
of decreasing ion mobility with increasing field strength (+CV). Large ions forming
adducts results in smaller effects on mobility compared to small ions forming adducts.
FAIMS technology originated in Russia during the early 1980s.95 The first refereed
reference to FAIMS was reported by Buryakov et al. in 199396 in which the general
principles were discussed and applied to the separation of tertiary alkylamines. The
technique of FAIMS was further developed by Purves and Guevremont 97 and has
since been applied to various effects as described in Table 1.1
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Table 1.1 Applications of ESI-FAIMS-MS 98
FAIMS devices uses a flowing a gas stream to transport ions through the space
between two electrodes or plates termed the analytical gap. The ions in the gap are
subjected to alternating strong and weak electric fields by the application of an
asymmetric waveform to the electrodes. Ions are separated by the difference between
their mobilities at high and low electric fields (E) that differ as ion mobilities in gases
depend on the field (E/N is ≤ 2 Td).  Therefore, it can be said that FAIMS measures
the mean derivative of mobility with respect to field (over a certain range of E), in
contrast to conventional IMS that determines absolute ion mobility, (K).99  The
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FAIMS device as stated previously consists of two electrodes which may be two
parallel plates (planar FAIMS) or two concentric cylinders (c-FAIMS, Figure 1.4)
between which ions are introduced.  The asymmetric waveform voltage is applied
across the two plates with a high positive voltage applied for a short period of time
and a low negative voltage is applied for a longer time period (Figure 1.5).   This is
termed the dispersion voltage (DV).  If the mobility of an ion under low field
conditions <200 volts/cm is different from its mobility at (> 5000 volts/cm) then the
application of the waveform may cause the ions to drift towards one of the plates.92
.
Figure 1.4 Separation of ions using FAIMS taken from Thermo Scientific.
The reason the ion will drift towards a plate is that if the ion mobility is different
when the electric field is high to when it is low, the ion will move proportionally
farther in one field than the other resulting in a net drift towards one of the electrodes.
This drift of an ion can be corrected by the application of a small dc voltage to either
plate, termed the compensation voltage (CV).  The CV is therefore, used within
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FAIMS to scan the FAIMS spectrum and control ion separation. By fixing the CV
value, a subset of ions is allowed to pass through the FAIMS device by controlling the
ions drift, whereas other ions are lost to the walls of the device and neutralised.  A
mixture of ions carried by a gas flow can therefore be transmitted selectively by
scanning the CV and detecting the ions travelling between the plates (Figure 1.5).
Each ion type travels through the device at a characteristic value of CV.
Figure 1.5 Schematic representation of the FAIMS device showing (a) the separation
process and (b) a schematic of the applied waveform.
      Dispersion voltage (DV)
(a)
(b)
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1.4 Mass spectrometry
“Mass spectrometry (MS) enjoys a rich heritage dating back more than a hundred
years” (R.M. Caprioli, 2002).  Since the first studies of J.J. Thomson (1912), mass
spectrometry has since undergone countless improvements including the coupling
with GC in the late 1950s, the discoveries of electrospray ionisation by Dole et al.100
and matrix-assisted laser desorption101 allowing molecules with high molecular
weights to be analysed and also the coupling of other separation techniques, LC102,
capillary electrophoresis,103 IMS44 and FAIMS.98 These advancements have allowed
for significant information including structure, composition and purity to be derived
from various sample types, chemical and biological, allowing mass spectrometry to
become an important and powerful analytical tool with limits of detection in the
femtomole/attomole range.
Mass spectrometry is a technique in which gaseous ions formed from the molecules or
atoms of a sample are separated in space or time and detected according to their mass-
to-charge ratio, m/z.  The number of ions of each mass detected constitutes a mass
spectrum, or in other words the peaks in a mass spectrum represent the ion current
measured by the instrument at a specific m/z ratio.  A mass spectrometer consists of a
sample introduction system, ionisation source, mass analyser and a detector (Figure
1.6)
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Figure 1.6 Simplified block diagram of a mass spectrometer 104
The sample is introduced into the ionisation region where gas phase analyte ions are
formed, these ions are then directed into the mass analyser which separates ions
according to their m/z ratio, and finally ions strike the detector, producing an ion
current.
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1.4.1 Ionisation techniques
The function of the ionisation source is to produce gas phase ions from the sample
molecules, which can then be separated by the mass analyser.  The ionisation source
may be held at either atmospheric pressure or under vacuum.  Several techniques have
been developed to overcome the problem of introducing the sample in a suitable form.
The research presented in this thesis used electrospray and desorption electrospray
ionisation. These are discussed in section 1.4.1.1 and 1.4.1.2.
1.4.1.1 Electrospray ionisation
Electrospray ionisation was introduced by Dole in 1968, 105 but only after
development in the 1980s by Fenn et al. 106 was success gained in the analysis of a
wide variety of biological molecules.  Electrospray ionisation also facilitated the
efficient interfacing of liquid chromatography with mass spectrometry. Electrospray
ionisation further lends itself to producing multiply charged ions and hence can
greatly extend the mass range of existing instruments.  More recently, low flow rate
variations such as nano electrospray107 have proved capable of excellent performance
with high sensitivity.
The electrospray interface operates at atmospheric pressure. The sample is dissolved
with a solvent and sprayed from a narrow tube or metal capillary tube into an electric
field obtained by applying a potential difference of 3-6kV between the tube and a
counter electrode. Electrospray is the result of charging such a liquid at the needle tip
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by the application of a high potential between the needle and counter electrode (the
cone). The formation of the aerosol depends on the competition between coulomb
repulsion and surface tension. When no potential is applied to the liquid flow, drops
fall off due to gravity and no electrospray is achieved, with the increase in potential
droplet size reduces, a liquid elongated liquid column forms with a sharp tip at its
point, the so called Taylor cone. When the potential is further increased
accumulation of charge on the surface coupled with evaporation (aided by a
desolvation gas) of the solvent, force the droplets to diminish is size until the
Rayleigh limit is reached.  At this point the force of coulombic repulsion between the
ions in the droplet is equal to the surface tension of the liquid.  As a result of these
forces, the droplet breaks up producing a number of smaller droplets.  This process is
repeated until the ions are fully desolvated, producing protonated or cationised ions in
the gas phase.
Figure 1.7 Droplet formation in electrospray ionisation 108
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In positive ion mode an enrichment of positive electrolyte ions occurs at the solution
meniscus (Figure 1.7). Charge balance is maintained by electrochemical oxidation at
the capillary tip and reduction at the counter electrode. When the Rayleigh limit is
reached, the droplets become unstable and undergo disintegration into smaller
droplets as described previously and produce the Taylor cone from which smaller
offspring droplets are formed.
There are two theories describing how gas phase ions may be produced from the
charged droplets. The charge residue model (CRM) proposed by Dole et al.109
proposes that the ion is converted to a gas phase ion by evaporation of solvent from a
droplet containing a single ion. A sequence of Rayleigh instabilities (where columbic
repulsion becomes greater than the surface tension) coupled with solvent evaporation
produce the final droplets which contain only one ion each. The ion evaporation
model (IEM) introduced by Iribarne and Thomsom110 assumes that before a droplet
reaches the final stages in the CRM model, the increased charge density or field on
the droplets surface coupled with solvent evaporation causes coulombic repulsion to
overcome the surface tension, resulting in an ion escaping from the droplet surface
and enter the gas phase.
1.4.1.2 Desorption Electrospray Ionisation
Desorption electrospray ionisation (DESI) was introduced by Takats and co-
workers111 in 2004 and has proved successful for producing gas phase ions directly
from the surface of samples, under ambient conditions, and without the need for a
matrix (MALDI) or sample pre-treatment. DESI uses fast moving charged solvent
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droplets from an ESI probe to extract analytes from surfaces under interrogation and
eject the secondary ions towards the mass spectrometer. Interaction between the
spray and the surface ionises the sample and the gas phase analyte ions are then
transported into the mass spectrometer.  A schematic representation of the DESI
process is displayed in Figure 1.8.
Figure 1.8 Schematic representation of the DESI process112
There is no requirement for sample preparation or matrix addition required with
MALDI and, as a result, analysis is rapid, making DESI a high throughput technique
with total analysis speed typically less than 5 seconds, or the time taken to present the
sample to the ESI spray. DESI can also be said to be a soft ionisation method similar
to that seen in ESI with internal energy distributions of ions produced around 2 eV,
with little fragmentation occurring.113
Currently the ionisation processes in DESI are not fully understood. However, a
number of ion formation mechanisms have been proposed, including the droplet pick
up mechanism, chemical sputtering114 and volatilisation of neutral species from the
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analyte surface. The main DESI mechanism has been described as the ‘droplet pick-
up’.115  The droplet pick up process is shown in Figure 1.9.
Figure 1.9 Schematic representation of the proposed droplet pick-up process for
DESI modified from reference 161
Analyte
Analyte air dried
Analyte exposed to electrospray
Droplet
Analyte is picked up by the droplet
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Measurements of droplet size and velocity distributions, as well as simulations and
other evidence based on spectral characteristics, including the strong similarity in
charge-state distributions, indicate that a droplet pick-up mechanism probably
operates under most circumstances. It is believed to involve the initial wetting of the
surface under interrogation whereby surface analytes dissolve or otherwise collect in
the solvent layer, followed by splashing on the arrival of subsequent droplets with
emission of secondary droplets containing the dissolved surface material and analyte
of interest. The wetting effect can often be visualised during the DESI experiment as
a build up of a surface liquid layer.  Muddiman et al.116 also indicated what was called
a ‘solvation delay’ in the ion intensities, observed when initially switching on the
DESI spray. The total ion current detected in the mass spectrometer was low at the
onset of the spray for 1-2s.  This delay could account for the time required for the
dissolution of analytes from the surface into the thin film layer. Further evidence for
this mechanism comes from simulations and experiments on the velocity and diameter
of the droplets as determined by phase Doppler particle analysis. 117  Simulations of
the DESI process showed the formation of microdroplets resulting from a single
droplet-thin film collision event and significant macro droplet expulsion from the
surface as seen in Figure 1.10.118
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Figure 1.10 Side view of contours for DESI 118
The last stage of analyte liberation from a droplet is proposed to be identical in DESI
to that observed in ESI. This hypothesis is supported by experimental measurement of
the internal energies of analyte ions in DESI through thermometer ion method and
comparison of internal energies from ESI .119
DESI ion sources can be easily constructed by modification of an atmospheric
pressure ESI interface, by introduction of a DESI target close to the ESI spray. DESI
conditions have been reported to influence the ionisation efficiency, analyte
specificity and overall signal intensity. These parameters include solvent, substrate
and geometrical positioning of the sample.  Solvent choice has been shown to greatly
affect the DESI ionisation efficiency as dissolution of the analyte is a key requirement
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in the droplet pick-up mechanism. Selected solvents and addition of modifiers to the
solvent spray provides specificity for the ionisation of analytes of interest.  A
correlation between the solubility of a compound in a particular solvent and the signal
response in DESI is seen and hence suitable solvents should be selected based upon
the sample under interrogation. The use of aqueous solvents increases the signal of
polar analytes, whereas organic additives enhance the signal of non polar analytes. 120
The addition of surfactant to the solvent spray was investigated with observations
indicating an increase in detection limits, with the effect being ascribed to the
reduction in surface tension.121 The addition of a reagent to the solvent can be
employed to modify the analyte via a chemical reaction at the sample surface, such
modification may involve derivatisation and is generally termed ‘reactive DESI’. The
potential value of reactive DESI was demonstrated by Cooks and co workers for the
DESI-MS analysis of a tissue section the resulting spectrum showed no signal for
cholesterol but gave a strong signal for the cholesterol derivative when betaine
aldehyde was added to the spray solvent.122  Other examples of reactive DESI include
anion addition123 and redox reactions.124  Investigations have also been carried out to
eliminate the formation of salt adducts. This work demonstrated that the addition of
0.1% ammonium acetate (7M) to the standard methanol:water (1:1) DESI solvent
spray, increased the salt tolerance of the DESI technique and displayed increased
signal-to-noise in comparison to ESI.125 Geometric parameters include the
positioning of the sample surface including the position of the incident and collection
angles (α and β respectively), the sprayer tip-to-sample surface (d1) and the sample
surface-to-MS  inlet distance (d2). α and d1 are known to have a direct effect on the
ionisation process whilst β and d2 influence the collection efficiency. Optimum
geometric parameters vary depending on sample type with an increased α angle
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typically lending to ESI type analytes, lower values of α typically lend to polar and
ionic compounds.126 Other important parameters influencing efficiency of DESI
process are displayed in Figure 1.11
Figure 1.11 Dependence of signal intensity of triply charged melittin ions on (a)
spray impact angle, (b) spray high voltage (c) nebulizing gas inlet and (d) solvent
flow rate.
(a) (b)
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Surface temperature and surface potential has also been shown to have an affect on
signal intensity, increasing surface temperature results in an increase in ionisation
efficiency.  APCI type analytes are affected to a greater degree by surface potential,
and are typically ionised when the potential difference between the spray tip and
surface is greater than 2 kV.
Due to the advantageous properties of DESI over other ionisation techniques the
application of DESI has grown considerably since its introduction in 2004.  The
application of DESI to pharmaceutical preparations, such as the desorption of active
pharmaceutical ingredients from tablets, patches and creams127,128,129,130 at levels as
low as 0.14% (w/w). Illicit drug detection has also been investigated with high
sensitivity and throughput for the screening of Ecstasy.131 The technique has shown
promise for the analysis of chemical warfare agents132 and the detection of explosives
(TNT, RDX, TATP)133,134,135 in forensic136 and public safety applications, with
analytes desorbed and detected at the low to mid femtogram level from a variety of
surfaces including, paper, plastic, metal and leather. The in-vivo sampling of tissues
by DESI, including the detection of pharmaceutical products or metabolites directly
from skin, saliva and bodily fluids (urine and blood)111,137,138,139 provides a non-
invasive alternative for bio-analysis with little or no sample pre-treatment. The
capability of DESI imaging had also been explored in the forensic analysis of inks as
a non-destructive method for detecting fraudulent documents.122 The imaging of
biological systems has been investigated to identify potential biomarkers of disease in
thin sections of rat brain tissue.140 Profiling of intact and untreated micro-organisms
has also been investigated.141  Combination with TLC and its use has been described
with normal phase silica gel142 and cellulose143 plates for the study of medicinal
ingredients,144 dyes,145 alkaloids,146 proteins and peptides147 and pharmaceutical
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formulations.148 The application of DESI to the analysis of analytes from
hydrophobic, reversed-phase TLC plates with bonded silica phases has been
investigated for the analysis of dyes.149,150,151 More recently, Wiseman et al. reported
the use of pressurised planar electrochromatography using reversed-phase C18 plates
for the study of steroids.152 DESI/MS has also been employed for the chemical
imaging of dyes separated on TLC plates138 and the desorption of analytes from non-
bonded, reversed-phase TLC plates by DESI. Other applications include the analysis
of bio-molecules, such as proteins153, tryptic and other peptides126,154,155 and
carbohydrates.156
DESI has been implemented as the ionisation source with many mass spectrometers,
including ion traps,157 orbitrap158, triple-quadrupoles and a hybrid quadrupole time-of-
flight (Q-ToF).159  DESI has also been coupled to IMS and has been reported for the
direct analysis of active ingredients in pharmaceutical formulations, demonstrating the
benefits offered by the additional dimension of IM.127 Further studies described the
use of DESI/IM-MS for the analysis of peptides160 and conformational studies of
folded and denatured states of proteins.161 In more recent investigations, DESI was
coupled with a travelling-wave based ion mobility-mass spectrometer for the analysis
of drugs.162
A DESI source has now been commercialised as the Omni Spray (Prosolia) developed
by Cook et al.163
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1.4.2 Mass analysers
The mass analyser region of the spectrometer separates ions according to their mass-
to-charge ration, m/z.  Ions generated in the source are accelerated into the analyser
chamber by applying potentials to a series of lenses through which they pass.  There
are several different types of mass analyser available, including magnetic sector,164
time-of-flight (ToF),165 Fourier Transform-Ion Cyclotron Resonance (FT-ICR)166 and
quadrupole devices.167  ToF, quadrupole and ion trap analysers were used in this
work.
1.4.2.1 Time-of-Flight (ToF) mass analyser
During the late 1950s the Cincinnati Division of the Bendix Aviation Corporation
introduced the first commercial time-of-flight mass spectrometer.168 In ToF
instruments the ions are formed in the source and ion bunches are accelerated into the
analyser, which is a field free region (Figure 1.12) Since all the ions are accelerated
by the same voltage and therefore, have the same kinetic energy, their velocity will be
a function of their mass.  Lighter ions will transverse the field free region more
rapidly than the heavier ions.  The time an ion takes to transverse the flight tube is
termed the flight time (t).  The m/z ratio of an ion can then be calculated from the
measured flight time.
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Figure 1.12 Schematic representation of a ToF flight tube.  Where; a corresponds to
the light ions, b to the heavier ions and c shows the ions becoming separated into
individual packets.169
The kinetic energy of an ion following acceleration from the source is given by the
equation:
KE = zeVacc = mv2/2                     Equation 1.11
Where z is the charge residing upon the ion, e equals the fundamental unit of charge
(1.602 x 10-19 C), Vacc is the accelerating voltage, v is velocity and m is the ion mass.
This equation can be rearranged to determine velocity of the ion in the flight tube
described by:
Ion source                                                                     detector
Field free region
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v = (2zeVacc/m)1/2 Equation 1.12
The velocity of an ion is related to the flight time (t) and the length (d) of the flight
tube employing the equation:
v = d/t                    Equation 1.13
By further rearrangement of the equations and substituting for v the m/z ratio can be
calculated from the measured flight time:
2
2 )2(/ d
eNtzm                                            Equation 1.14
However, many ToF spectrometers are fitted with reflectron lenses to improve
resolution by increasing the ions flight path, and hence the calculation of m/z becomes
more difficult.
In practice the simplified equation (1.15) is employed to determine m/z ratios from
measured flight times:
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m/z = at2 + b          Equation 1.15
Where a and b refer to constant values obtained from reference compounds of known
molecular weight for a given set of instrument conditions.
ToF spectrometers have, theoretically, an unlimited mass range however, in practice
very large ions may not generate a significantly large enough current when they hit
the detector plate. Nevertheless, ToF analysers are capable of detecting molecules
with a molecular mass in excess of 300kDa.
The introduction of an electrostatic reflector or reflectron into the ToF was used to
overcome poor resolution seen in the linear ToF (Figure 1.13). Ions that have higher
kinetic energies will arrive at the reflectron before ions of the same mass, but with
lower kinetic energy. However, they will also penetrate further into the electrostatic
field than the lower kinetic energy ions, this results in their flight time in the
reflectron increasing compared to low kinetic energy ions.  The delay of high kinetic
energy ions enables the slower moving ions to arrive at the detector at the same time
as the high kinetic energy ions due to the fact that they spend less time in the
electrostatic field.
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Figure 1.13 schematic of reflectron ToF instrument showing focusing of ions of
similar mass but different kinetic energy.170
The reflectron focuses the kinetic energy distribution of the ions and hence the
reflectron ToF gives mass resolution in the range of >10000 compared to >1000 with
a linear ToF.
1.4.2.2 Quadrupole mass analysers
The concept of quadrupole mass spectrometers, which utilise electrical fields to
separate ions based upon their m/z ratio, was introduced in the early 1950s by
Wolfgang Paul, who shared the 1989 Nobel prize for physics.171  Paul showed that
ions in quadrupole fields were either stable or unstable depending on their m/z ratio
and the geometrical structure and electrical parameters of the field. In a linear
quadrupole, the fields could be adjusted to allow transmission of an ion with a
specific m/z ratio from one end of the quadrupole to the other.  It was also shown that
a cubic quadrupole could be employed to either trap a single ion of m/z ratio or a
High KE ions
Low KE ions
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range of ions and that the later  ions could be ejected in sequence by modification of
the field.
Figure 1.14 Schematic representation of a linear quadrupole taken from reference 172
The quadrupole itself consists of four rods (Figure 1.14), which are either circular or
hyperbolical in cross section. Superimposed RF and DC voltages are applied to these
rods, which are electrically connected in opposing pairs. Ions passing through the
quadrupole may have resonant or non-resonant frequencies; only ions with resonant
frequencies will have a stable trajectory and be transmitted through the quadrupole to
the detector.
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The stability of an ion can be determined from Newton’s second law (force = mass x
acceleration) which gives equation 1.16. This equation is also termed the Mathieu
equation:
D2u/dξ2 + (au-2qcos2ξ)u = 0                    Equation 1.16
Where u = x or y and ξ = π ft (f=frequency, t=time).  The a and q terms are
dimensionless and for ions within a quadrupole field are:
ax = -ay= 8eU/mr02Ω2             Equation 1.17
qx = -qy= -4eV/mr02Ω2                    Equation 1.18
Where m is the mass of an ion travelling through a quadrupole of radius r0. The
quadrupole is operated with RF (V) and DC (U) potentials and a main RF angular
drive frequency
(Ω = 2πf)                    Equation 1.19
Ion trajectories can be further described by the Mathieu stability diagram. Ions must
have stable trajectories in both the x and y directions to transverse the quadrupole and
ions whose working point lies within the boundaries are stable in both directions and
hence will pass through the quadrupole. Ions lying outside this boundary have non-
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resonant trajectories in either both or one direction and hence will not transverse the
quadrupole and be detected.
Figure 1.15 Linear quadrupole stability diagram modified from reference 104
As the RF and DC voltages increase the working point of an ion will move along one
of the lines indicated in Figure 1.15 under optimum conditions. Ions of increasing m/z
will pass through the apex of the stability diagram where they have stable a and q
values. Ions of lower or higher m/z will not have stable trajectories at this same point.
The quadrupole mass anlyser separates ions only on the basis of their m/z ratio, it
therefore can be said that instruments that use this concept act as true mass filters.
Stable in x
and y
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In a linear quadrupole ion trap, ions are introduced into the quadrupole and retained in
stable trajectories by applying a potential to each end of the device. Ions are ejected
by a mass-selected instability scan to obtain a mass spectrum.  A significant problem
with ion tap technology is that peak broadening can occur due to overloading of the
trap itself with analyte ions, leading to space charging effects.  The ions retained in
the trap repel like charged ions so that ions of the same m/z occupy different working
points on the stability diagram and are ejected at slightly different times during the
analytical scan and hence causing broadening of the spectral peaks. To overcome this
problem a software modification known as automatic gain control (AGC) was
devised, which performs a short pre-scan before the main scan and thus measures the
number of ions entering the trap. The analytical scan ion time can therefore be
calculated so that an overload of ions does not occur, preventing space charging
effects.
Quadrupole instruments have been further developed utilising multiple quadrupoles
and allowing for tandem mass spectrometry to be performed. In a triple quadrupole
the first quadrupole is employed as a mass filter to select precursor ions , the second is
operated in RF mode only to ensure all ions are transmitted.  This second quadrupole
is maintained at a constant pressure with a suitable gas, primarily He or Ar to act as a
collision cell where the precursor ions undergo fragmentation. The third quadrupole is
used to scan the mass spectrum of the fragment ions.  Quadrupoles have also been
coupled to ToF instruments whereby the third quadrupole is replaced with ToF flight
tube giving a Q-ToF configuration.
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1.4.3 Detection systems
Several different types of detector are used within mass spectrometry however, they
can be further categorised into two components, the Faraday plate,173 which directly
measures the current of the ions striking a metal plate and the other detectors.   Other
detector types include such detectors as the array detector,174 electron multipliers175
and photomultiplier tubes176 which all increase the intensity of the original signal
producing much higher measured currents.
1.5 Introduction to Metabonomics
Since the 1990s, there has been a revolution in the techniques and approaches used in
molecular biology and biochemistry directly following the human genome
project177,178 and the subsequent decoding of the human genome. This change, led to
the idea that genetic differences might be able to account for all disease processes,
and in turn led to the discipline of transcriptomics.  Further advancements in the
ability to assay and identify proteins using mass spectrometry and other techniques
led to the term proteomics. However, during the past few years the full complexity of
molecular biology has been realised and the complex interactions between genetic
make-up and environmental factors have now been recognised.  It is now accepted
that a full understanding of these interactions is not possible at the transcriptomic and
proteomic level alone.  Even in combination, genomics and proteomics do not provide
the range of information needed for an understanding of the integrated cellular
function in living systems, since both ignore the dynamic metabolic status of the
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whole organism.179  A further point is that the number of metabolites is around 5000,
compared with 1,000,000 estimated proteins and over 20,000 genes in humans.180
Small molecules involved in biochemical processes provide information on the status
and functioning of a living system, both from effects caused by changes in gene
expression and also by differences in life style, diet, and environmental factors.  The
process of monitoring and evaluating such changes is termed metabonomics.181
The field of metabonomics grew out of work carried out in the mid 1980s 182,183,184,185
and which was subsequently combined with pattern recognition and multivariate
statistic investigation of the data sets to yield possible biomarkers.  However, the term
metabonomics was not suggested until 1999 and was defined by Nicholson et al. as
“the quantitative measurement of the dynamic multiparametric metabolic response of
living systems to pathophysiological stimuli or genetic modification”.179  There is also
a related concept of the metabolome or metabolomics, which has been consistently
used interchangeably with metabonomics throughout many texts. However, the
metabolome represents the total small molecule complement of a cell, whereas
metabonomics refers to the process of quantifying, identifying, and cataloguing the
history of time related metabolic changes in an integrated biological system rather
than an individual cell.179
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1.5.1 Samples for metabonomics
Metabonomic studies of biomedical relevance generally use biofluids, cell or tissue
extracts.  These include, breath, urine, sputum, (Figure 1.16) and can provide an
integrated view of the whole systems biology. Urine and plasma are obtained
essentially non-invasively and hence lend themselves for disease diagnosis and
clinical trail settings. However,  a wide range of fluids and sample type have been
investigated including, seminal fluids, amniotic fluid, digestive fluids, lung aspirate
and dialysis fluid.  Analysis of tissue biopsy has also been conducted employing
NMR spectroscopy in studies of atherosclerosis.186  Metabonomics can also be
applied to characterising in vitro systems for example, tumour cells.
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Figure 1.16 Scheme for mass-spectrometry based omics technologies modified from
reference 187
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1.5.2 Analytical Techniques for metabonomic analysis
A number of analytical methods can be employed to produce metabolic signatures of
biomaterials, including high resolution 1H nuclear magnetic resonance (NMR)
spectroscopy,188 gas chromatography-mass spectrometry (GC-MS),189 liquid
chromatography-mass spectrometry (LC-MS),190 ultra high performance liquid
chromatography- mass spectrometry (UHPLC-MS)191 and capillary electrophoresis-
mass spectrometry (CE-MS).192 All metabonomic studies result in complex
multivariate data sets, which in turn require bioinformatic methods for visualisation
and interpretation. High resolution 1H nuclear magnetic resonance (NMR)
spectroscopy has proved to be one of the most valuable and most powerful
technologies for biofluids due to its non-destructive nature, application to intact
biomaterials, tissues and cells, and the elucidation of molecular structure.193 NMR
spectroscopy is capable of recording many metabolites either in vivo or in vitro.
However, there are limitations for NMR-based metabonomic studies including low
resolution and sensitivity (>1 nmol metabolite for 1H-NMR detection) and the
inability to detect NMR inactive nuclei (e.g. O & S) and difficulties in absolute
metabolite quantification.  MS is inherently more sensitive than NMR, but is a
destructive technique.  MS is also a major technique for molecular identification,
especially through tandem MS fragmentation studies or measurement.
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1.5.3 Overview of metabonomics
Nicholson et al. used NMR spectroscopy to study multicomponent metabolic
composition of biofluids. A typical example is the extensive study of the toxicity of
the model hepatotoxin, hydrazine, in the rat by analysis of urine and blood.194 Dose
dependant trajectory plots showed increasing metabolic insult and recovery with
Krebs cycle intermediates being shown to decrease in dosed animals. NMR
spectroscopy continues to be a valuable tool within metabonomics but due to
sensitivity issues mass spectrometry is quickly becoming a powerful method of choice
either used in combination with NMR or alone.  Due to the scope of this research,
emphasis will be directed towards MS only applications.
MS has been widely used in metabonomics for metabolic fingerprinting, identification
and the elucidation of biomarkers as well as becoming the “powerhouse”195 of the
pharmaceutical and biotechnology industry for metabolic fingerprinting of drugs.  The
majority of MS-based studies within the literature have been directed towards plant
extract studies.196,197  However, the application of MS to mammalian studies is
increasing.  For metabonomic applications on biofluids such as urine,198 an HPLC
chromatogram is generated with MS detection, usually employing electrospray
ionisation and both positive and negative ion spectra can be measured.  At each point
in the chromatogram, there is a full mass spectrum, providing retention time, mass,
and intensity data sets.  UPLC has enabled better chromatographic peak resolution,
increased speed and sensitivity to be obtained for complex mixture analysis.  A
comparison of HPLC and UPLC for mouse urine samples was investigated by Wilson
et al.199  The study showed that UPLC offers significant advantages, including more
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than a doubling of peak capacity, an almost 10-fold increase in speed and a 3-5-fold
increase in sensitivity.
Early developments of metabonomic studies included the chemotaxonomic
discrimination of Pencillium cultures via identification of strain specific
metabolites.200 Bacterial characterisation and identification on free cell extracts has
been studied and species specific peaks identified for Escherichia coli, Bacillus spp
and Brevibacillus laterosporus.201  Metabonomic studies have been used to
investigate the effects of aging and development in Wister-derived rats by analysis of
urinary profiles and the endogenous metabolites excreted.  It was found that, through
multivariate data analysis which enables visual clustering effects, that urine collected
at 4-6 weeks of age showed the greatest differences in metabolite profiling for
example carnitine was found to increase with age.202  Clinical diagnostic applications
provide screening of large number of samples through targeted analyses of specific
metabolites indicative of metabolism disorder. Postmortem diagnosis by analysis of
bile fluid or urine have indicated metabolic disorders that may have resulted in sudden
infant death syndrome.203 The combined approach of coupling IMS to MS for
metabonomic analysis has also been investigated.  The mobility dimension provides
additional information, which can be generated and gathered from the metabonomic
data and hence provide a novel technique for metabonomic investigations. The
metabolic profiling of E.coli87 and drug metabolites204 have been investigated and the
metabonomic study of rat urine reported.205 More recently the metabolic profiling of
blood by IM-MS has been reported.205
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It seems likely that ultimately a combination of technologies will prove to be the most
useful in the exploration of metabonomics. However, the additional dimension of IMS
is being realised, demonstrating the potential to enhance metabonomic coverage by
the introduction of a gas-phase electrophoretic separation.
1.6 Introduction to data mining methods
Data mining can be defined as the process of extracting patterns from large data sets.
Data mining is seen as an increasingly important analytical tool as modern analysis
methods provide opportunities to generate huge volumes of data with every analysis.
It has become routine that spectroscopic methods provide analytical data on many
components of a single sample, where several variables are measured. A spectrum
would normally be characterised by several hundred to several thousand m/z and
intensity measurements. The aim of data mining methods is to reduce the volume data
whilst maintaining the relevant information and to find patterns and relationships
within the vast quantity of data generated.  Data mining can only uncover patterns
already present in the data; the target dataset must be representative to contain these
patterns while remaining concise enough to be mined in an acceptable timeframe.206
Before data mining algorithms can be used, a target data set must be assembled, with
noise and missing data points removed. Data is reduced into feature vectors, one
vector per observation which dramatically reduces the size of the dataset to be mined,
and hence reducing the processing timeframe. The feature(s) selected will depend on
what the objective(s) is/are; obviously, selecting the "right" feature(s) is fundamental
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to successful data mining207. The feature vectors are divided into two sets, the
"training set" and the "test set". The training set is used to "train" the data mining
algorithm(s), while the test set is used to verify the accuracy of any patterns found.
The final step of data mining is to verify the patterns produced by the data mining
algorithms occur in the wider data set. It is common for the data mining algorithms to
find patterns in the training set which are not present in the general data set, this is
called over fitting. To overcome this, the evaluation uses a test set of data which the
data mining algorithm was not trained on. The learnt patterns are applied to this test
set and the resulting output is compared to the desired output. If the learnt patterns
meet the desired standards the interpretation of the data can be carried out.
1.6.1 Principal component analysis.
Principal component analysis (PCA) is a technique for reducing the amount of data
when there is correlation present, with the prime objective to find principle
components. PCA is a mathematical procedure that transforms a number of (possibly)
correlated variables into a (smaller) number of uncorrelated variables called principal
components. The objective of principal component analysis is to reduce the
dimensionality (number of variables) of the dataset but retain most of the original
variability in the data.208 Principal components are chosen so that the first principal
component (PC1) accounts for most of the variation in the data set, the second (PC2)
accounts for the next largest variation and so on. When significant correlation occurs
the number of useful PCs is reduced and far fewer than the original variables and
hence reduces the amount of data. Each component accounts for a maximal amount of
variance in the observed variables that was not accounted for by the preceding
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components, and is uncorrelated with all of the preceding components. A principal
component analysis proceeds in this fashion, with each new component accounting
for progressively smaller and smaller amounts of variance.209 As variance is a
measure of the spread of data in a data set, PCA can be employed to determine
whether an experimental study has remained within control limits and if the data
shows correlation. For example a full metabonomic study data set will contain 1000’s
of variables in order to determine if correlation is observed PCA analysis could be
employed. Throughout this research PCA analysis was employed to determine if the
analytical system remained within control limits and hence to determine the validity
of the generated data.
1.6.2 Artificial Neural Networks
In a simple form ANNs attempt to imitate the operation of neurons in the brain. Such
networks are constructed of linked layers of artificial neurons which includes an input
and output layer, Figure 1.17.210 Variables are presented to the input layer and
processed by one or more of the hidden layers to produce one or more outputs. The
network is trained by employing a training set, where the system will adapt based
upon the training information. Discrepancies between the observed and predicted
values during the training phase are used to adjust internal parameters in the network.
These steps, prediction and adjustment, are repeated until the desired outcome is
achieved. The performance of the network is evaluated employing a training set,
though care is needed to ensure that over fitting has not occurred. ANNs are normally
employed to find patterns in large data sets containing many variables.
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Figure 1.17 Example of a neural network211
The neural network does not start by assuming a particular type of relationship
between the input and output variables, it is therefore useful when the underlying
mathematical model is uncertain.206  ANNs are versatile and flexible tools for
modelling complex relationships between variables. During this research ANNs were
employed to find correlation between age groups of rats from their urinary profile.
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CHAPTER TWO
The application of desorption electrospray
ionisation-ion mobility-mass spectrometry
for pharmaceutical analysis.
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2.1 INTRODUCTION
Studies investigated the direct analysis of pharmaceutical formulations and active
ingredients in caplet form and from non-bonded reversed-phase thin layer
chromatography (RP-TLC) plates by desorption electrospray ionisation (DESI)
combined with ion mobility-mass spectrometry (IM-MS) is reported.  The analysis of
formulations containing analgesic (paracetamol), decongestant (ephedrine),anti-
foaming (Simethicone), opioid (Codeine/Loperamide) and stimulant (Caffeine) active
pharmaceutical ingredients is described, with and without chromatographic
development to separate the active ingredients from the excipient formulation.
Selectivity was enhanced by combining ion mobility and mass spectrometry to
characterise the desorbed gas-phase analyte ions on the basis of mass-to-charge (m/z)
ratio and gas-phase ion mobility (drift time).  Varying the solvent composition of the
DESI spray using a step gradient was employed to optimise the desorption of active
pharmaceutical ingredients from the RP-TLC plates. The combined RP-
TLC/DESI/IM-MS approach has potential as a rapid and selective technique for
pharmaceutical analysis by orthogonal gas-phase electrophoretic and mass-to-charge
separation.
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2.2 CHAPTER TWO AIMS AND OBJECTIVES
This chapter describes an investigation to develop a fast, novel method on the
detection of pharmaceutical formulations employing desorption electrospray
ionisation (DESI) coupled with ion mobility – mass spectrometry (IM-MS). Active
pharmaceutical ingredients were analysed directly from tablets and in combination
with reversed phase thin layer chromatography plates (RP-TLC).
Thin layer chromatography (TLC) remains a widely used technique for the separation
of mixtures for both qualitative and quantitative analysis, but has limitations with
respect to the identification of the separated analytes. To overcome this limitation
there have been many attempts to couple TLC with MS using ionization techniques
such as fast atom bombardment (FAB) and matrix assisted laser desorption ionisation
(MALDI).1  In this context, DESI as a sample introduction method for MS seems
ideally suited to combination with TLC and its use has been described with normal
phase silica gel2 and cellulose3 plates for the study of medicinal ingredients,4 dyes,4,5
alkaloids,6 proteins and peptides7 and pharmaceutical formulations.8
The application of DESI to the analysis of analytes from hydrophobic, reversed-phase
TLC plates with bonded silica phases has been investigated for the analysis of
dyes.9,10,11 More recently, Wiseman et al. reported the use of pressurised planar
electrochromatography using reversed-phase C18 plates for the study of steroids.12
DESI/MS has also been employed for the chemical imaging of dyes separated on TLC
plates.9  The desorption of analytes from non-bonded, reversed-phase TLC plates by
DESI has not been previously reported and presents additional challenges because the
plates cannot be pre-cleaned to reduce background contamination prior to analyte
deposition and there may be interference from stationary phase molecules being
desorbed together with the analyte.
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The specific objectives were:
 To investigate the potential of DESI/IM-MS analysis of pharmaceutical drug
formulations to increase selectivity and to characterise and separate analytes of
interest with little or no sample preparation.
 To investigate the application of DESI for the direct, rapid ion mobility mass
spectrometric analysis of active pharmaceutical ingredients from the surface of
bonded and non-bonded RP-TLC plates, with or without separation from the
excipient components.
 To evaluate the potential of ion mobility as a pre-separation technique for gas
phase ions generated by DESI for active-pharmaceutical ingredients.
 To asses the potential of RP-TLC/DESI-IM-MS for chemical imaging.
 To investigate the potential of varying the solvent composition of the DESI
solvent spray to provide on-line optimisation of the method for reduced
analysis times.
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2. 3 EXPERIMENTAL
2.3.1 Chemicals
Acetonitrile (HPLC gradient grade), methanol (HPLC gradient grade) and water
(HPLC grade) were purchased from Thermo Fisher Scientific (Loughborough, UK).
Mass spectrometry grade (puriss, p.a) formic acid was purchased from Sigma-Aldrich
(Gillingham, UK).   Generic Co-codamol tablets containing 500 mg paracetamol and
8 mg codeine, generic cold and flu tablets containing 250 mg paracetamol, 25 mg
caffeine and 8 mg ephedrine and Sleepeaze (Boots, Nottingham, UK) containing
diphenhydramine 25 mg were purchased over the counter. Imodium plus caplets
(Johnson & Johnson, MSD) containing Loperamide hydrochloride (1) and
Simethicone (2) were purchased over the counter.
(1) (2)
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2.3.2 Desorption electrospray ionisation/ ion mobility-mass spectrometry analysis
of Imodium plus caplets.
All experiments were carried out employing a prototype IM-quadrupole time-of-flight
mass spectrometer (Waters Corporation, Manchester). The atmospheric pressure
ionisation (API) region of a Z-spray electrospray ionisation source was modified for
DESI by attaching a section of TLC plate to a manipulator, allowing horizontal,
vertical and rotational manipulation of the plate, which was located in the atmospheric
pressure ionisation region of the mass spectrometer at an approximate 45° angle
relative to the spray tip and cone, Figure 2.1.  A Waters Alliance 2790 chromatograph
(Waters Corporation, Manchester, UK) was coupled to the modified DESI ion source
of the IM-Q-ToFMS spectrometer to provide the DESI solvent flow.
Figure 2.1.  (a) Schematic diagram of DESI source and mass spectrometer interface,
(b) photograph of the DESI sample stage (c) photograph of the DESI ion source
region.
Reversed phase
TLC plate
(a)
(b)
(c)
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DESI was performed by attaching half a broken Imodium Plus tablet, (with internal
portion of tablet exposed to DESI spray to overcome problems associated with the
tablet coating), to the plate on the x,y manipulator which was placed in the
atmospheric pressure ionisation region of the mass spectrometer at an approximate
45° angle relative to the spray tip and cone. The area of sample desorbed when the
ESI probe and sample position were optimised was 1mm diameter (3.14 mm2), which
corresponds to the incident DESI solvent spray at the sample surface.
Ions from the DESI source were directed into the trap region at the head of the ion
mobility drift cell. The instrument was operated in positive ion mode with the ESI
capillary voltage set to 3.1 kV; cone voltage 60 V; source temperature 120 °C;
desolvation gas, N2 gas flow 250 L/hr; desolvation gas temperature, 180 °C.  The
quadrupole was operated in wide band pass mode (m/z 50-1000) and the collision cell
operated without any collision gas. The IM-Q-ToFMS was operated in positive ion
mode with the ESI capillary voltage set to 3.5 kV; cone voltage 40 V; source
temperature 120 °C; desolvation gas, N2 gas flow 250 L/hr; desolvation gas
temperature, 180 °C. Ions from the DESI source were directed into the trap region at
the head of the ion mobility drift cell and periodically gated into the drift cell, which
was operated in the pressure region of 1.0 to 3.0 Torr N2, using a gate electrode pulse
(3.50 V, 200 µs pulse width and 15ms pulse period). The IM drift tube consisted of a
multi-plate ion guide (15.2 cm in length) to which a voltage gradient (14.24 V/cm and
a supplement RF voltage 3.8 V) were applied.  Ions passing through the drift region
were then directed through the quadrupole and collision cell into the reflectron TOF
mass analyser. The quadrupole was operated in wide band pass mode (m/z 50-1000)
75
and the collision cell without any collision gas.  Ion mobility spectra were acquired by
collecting data from 200 ToF pushes (45 µs per bin) and plotting drift time (scan
number) against mass-to-charge ratio (m/z).  IM-MS data were typically accumulated
for 5 s, with a 2 s interscan delay. Acquired data were presented as a plot of time
against ion intensity; total ion mobility response or selected ion mobility responses.
Masslynx version 4.1 (Waters Corporation, Manchester, UK) was used to control the
IM-MS instrument and for data acquisition and processing.
Figure 2.2 Schematic of prototype IMS-Q-ToF
Gate
Mobility Device
N2 buffer gas
Trap
Quadrupole
Mass Filter
Ions from
source
Pusher
MCP Detector
Reflectron
LensesGas Cell
Transfer Optic
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2.3.3 Sample preparation for the desorption electrospray ionisation/ ion
mobility-mass spectrometry analysis combined with reversed-phase thin layer
chromatography.
Tablets were crushed and extracted in water (2 mL) and filtered (Whatman filter
paper, qualitative).  The extracted solution was manually spotted onto the reversed-
phase hydrocarbon impregnated silica gel TLC plates (Analtech Uniplates, Newark,
USA; 10 x 20 cm, 250 microns) in 1 µL aliquots up to 6 µL in total volume.  The
plates were developed in a saturated chamber with 50/50 (v/v) methanol-water.  A
saturated chamber containing iodine crystals was used to develop the TLC plates.
2.3.4 Desorption electrospray ionisation/ ion mobility-mass spectrometry analysis
combined with reversed-phase thin layer chromatography
The DESI/IM-MS ion source region is shown in Figure 2.1. All experiments were
carried out employing the prototype IM-quadrupole time-of-flight mass spectrometer
(Waters Corporation, Manchester) Figure 2.2. A split was employed to reduce the
solvent flow rate to the DESI probe (typically 25 µL/min) from the higher flow
through the LC system (200 µL/min).  The area of sample desorbed when the DESI
probe and sample position were optimised was approximately 1 mm in diameter.
Variable solvent composition experiments were carried out in which the TLC plate
was analysed using three different solution compositions using the following step
gradient: 10% A (0-1.5 min), increased to 50% A (1.5-3.0 min) and then to 90% A
(3.0-4.5 min), where A = 0.1% aqueous formic acid and B = 0.1% formic acid in
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acetonitrile.  At each gradient step change the DESI source was moved in the vertical
plane ensuring that an area of the TLC plate under interrogation had not previously
been exposed or desorbed.  Solvent and gas flow directed at the ionisation surface
also creates a washing effect.  The vertical movement of the sample stage ensured that
that the solvent plume from the previous row was not interrogated.
The IM-Q-ToFMS was operated with the same parameters as in section 2.3.2 page 74.
2.4 RESULTS AND DISCUSSION
2.4.1 DESI/IM-MS of tablet formulations
Imodium is a tablet formulation prescribed for stomach upset and diarrhoea.  The
active pharmaceutical ingredients are, Loperamide (2 mg) and Simeticone (containing
an equivalent to 125 mg of poly (dimethyl siloxane (PDMS)).  The tablet was
analysed after being broken in half, with the non-coated portion of the tablet being
interrogated by the DESI solvent plume allowing direct analysis without sample pre-
treatment. The resulting DESI spectrum displayed the oligomers of PDMS including
the Na+ adducts and the active ingredient Loperamide (Figures 2.3 to 2.6). However,
the mass spectra obtained were dominated by ions from the oligomers of PDMS as
shown in the m/z vs drift time (bins) plot (Figure 2.3). A significant increase in the
relative intensity of the protonated Loperamide was obtained by combining only the
bins corresponding to the selected ion mobility response for Loperamide (m/z 477.23,
bins 57 to 65) (Figure 2.4 (b)) compared to the mass spectrum obtained by combining
all 200 bins (Figure 2.4 (c)). Figure 2.4 (c) corresponds to mass spectral analysis in
the absence of IM separation.  The DESI technique required minimum sample
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preparation and the IM separation allowed the acquisition of MS nested data sets to be
acquired in the IM timescale. The use of data mining methods can be employed to
improve visualisation of the data and to serve as a powerful aid to extract information
on specific analytes, allowing only relevant information to be extracted.  The data
mining method employed in these investigations was the Driftscope TM mobility
environment software (Waters Corporation).  Driftscope TM software displays the drift
time vs the m/z for each ion present in the data.  The bands of colour in the drift time
vs m/z plots (Figure 2.3) represent the intensity of the ion, with red indicating regions
of highest intensity. Regions of interest may be selected and interrogation of the
corresponding mass spectra carried out. The Additional dimension of IM and data
mining improved selectivity for the active ingredient, Loperamide. These results
indicate that by employing direct DESI/IM-MS for the analysis of solid
pharmaceutical formulations, significant improvement in selectivity using IMS
compared to MS alone can be achieved.
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Figure 2.3  Drift time (bins) vs. m/z plot of DESI/IM-MS analysis of Imodium plus
caplets
Drift time (bin)
m/z
X 1 X 1
X 2 X 2
X 3 X 3
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Figure. 2.4 Spectra corresponding to selected ion mobility response for Loperamide
(m/z 477.23) from Figure 2.3. (a) Selected ion mobility spectrum (m/z 477.23) and (b)
mass spectrum obtained by combining bins 57 to 65 for m/z 477.13 (c) mass spectrum
obtained by combining all 200 bins.
The data can be manipulated to extract mass and ion mobility spectra from selected
regions from the drift time vs m/z plots, Figure 2.3.   Three sections were selected
from Figure 2.3 and averaged together to give a mobility spectrum and corresponding
mass spectrum of each section.  Figure 2.5, (a), (b) and (c) displays the three regions
corresponding to Figure 2.3, X1, X2 and X3.
Loperamide
m/z 477.23
(a)
(b)
(c)
m/z
Bin
% I
% I
% I
m/z
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Figure 2.5 DESI/IM-MS analysis of Imodium.  Ion mobility spectra and
corresponding mass spectra for selected regions of Figure 2.3. (a) selected region X1
(b) selected region X2 (c) selected region X3.
Drift time (bin)
%
X 3 Drift time (bin)
m/z
X 1
X 1
X 2
X 2
X 3
Drift time (bin)
Drift time (bin)
m/z
m/z
%
%
%
%
%
(a)
(b)
(c)
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Data mining of Figure 2.3 therefore allows spectra to be enhanced and thus provides a
means to reduce the complexity of the full data plot.
Figure 2.6 displays the ion mobility responses for the main PDMS polymers present
in the Imodium tablet. Electrospray ionisation mass spectrometry (ESI-MS) and
DESI-MS have previously been employed to characterise PDMS. However, IM was
employed during this study to increase the selectivity of the analysis. The results show
that as the m/z of the oligomers increases, the drift time also increases (Figure 2.6).
An increase in drift time is consistent with an increase in size of the polymer and in
turn the collision cross section, Ω. Comparison of the PDMS drift times (Figure 2.6
and Table 2.1) suggests that the n= 5 and 6 oligomers can be distinguished from each
other by drift time within the precision of the measurement (± 0.045 ms).  Calculated
drift times are presented in Table 2.1 along with tentative assignments, m/z and
corresponding empirical formulas for the oligomers of PDMS and Loperamide.
Comparison of drift times between the protonated PDMS oligomers and the Na+
adducts shows an increase in 0.09 ms for both the n=5 and n=6, however an increase
of 0.04 ms was observed for the n= 7 oligomer.
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PDMS investigations
Figure 2.6  DESI/IM-MS analysis of Imodium tablet. Selected ion mobility responses
of PDMS excipients (a) 1 (n=7) Na+, (b) 1 (n=7), (c) 1 (n=6) Na+, (d) 1 (n=6), (e) 1
(n=5) Na+, (f) 1 (n=5), (g) Total ion response.
Table 2.1 Proposed assignment of PDMS excipients, including calculated drift times
for each of the assigned oligomers.
.
C10H31Si5O5
C10H30Si5O5Na
C12H37Si6O6
C12H36Si6O6Na
C14H43Si7O7
C14H42Si7O7Na
C29H34ClN2O2
2.20
2.29
2.38
2.47
2.61
2.65
2.70
371.1
393.1
445.1
467.1
519.1
541.1
477.23
1 (n=5) H+
1 (n=5) Na+
1 (n=6) H+
1 (n=6) Na+
1 (n=7) H+
1 (n=7) Na+
Loperamide
Assignment
Empirical
formula
Drift time
(ms)
m/z
Drift time (bin)
(a)
(b)
(c)
(d)
(e)
(f)
(g)
1 (n=7) Na+
1 (n=7) H+
1 (n=6) Na+
1 (n=6) H+
1 (n=5) Na+
1 (n=5) H+
TIR
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2.4.2 DESI/IM-MS analysis of non-bonded RP-TLC plates
Pharmaceutical formulations containing paracetamol, caffeine, codeine and ephedrine
were analysed by DESI/IM-MS directly from the surface of non-bonded RP-TLC
plates, generating mass-to-charge and mobility data for the desorbed ions.
Optimisation of  the positioning of the sample relative to the atmospheric pressure
ionisation region of the mass spectrometer, including the spray tip and cone (Figure
2.1) was found to be a critical parameter influencing analyte signal intensity.  The
optimum position was determined by manipulation of the sample in the horizontal,
vertical and rotational planes with the maximum analyte response observed at an
angle of 45° relative to the spray tip and cone.  A further parameter found to effect
analyte responses significantly was the DESI solvent flow rate.  An increase in flow
correlated with an increase in analyte signal response and the amount of analyte
desorbed from the RP-TLC plate surface.  The signal intensity for the active
ingredients paracetamol and codeine showed a nine-fold increase when the DESI
solvent flow rate was increased from 2 µL/min to 5 µL/min.  A further increase in ion
intensity was observed up to a flow rate of 50 µL/min, but only a small increase in
signal response was observed at flow rate above an optimised flow of 25 µL/min. The
TLC plates showed a clear “wetting effect”, with a solvent layer forming on the
surface under interrogation by the incident electrospray, which facilitates the
extraction of analytes from the surface into the thin liquid layer.
High noise levels were observed in the resulting DESI mass spectra, presumably as a
result of interferences present on the plate or ablation of the hydrocarbon stationary
phase, which was a non-bonded phase and could not, therefore, be washed prior to
sample loading. IM-MS data were acquired by scanning of nested data sets, with mass
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spectra (45 s/scan) and IM spectra (~13 ms) scanned repetitively throughout the run.
Spectra were accumulated to yield 200 mass spectra and one ion mobility spectrum
every 7 s. The ion mobility drift time is plotted as ‘bins’, where each bin corresponds
to an acquired mass spectrum. The nested data acquisition of IM and MS data results
in an analysis incorporating a gas-phase electrophoretic separation of the ESI
generated ions on the basis of charge state and collision cross section (i.e. size and
shape), between the  mass analysis, all within the timescale of the MS run.
Total ion and selected ion mobility responses for the active pharmaceutical
ingredients extracted from a generic cold and flu tablet, including ephedrine,
paracetamol and caffeine, deposited on the TLC plate without solvent development,
are displayed in Figure 2.7 Selected ion responses for protonated ephedrine (m/z 168;
Figure 2.8 (a)), paracetamol (m/z 152; Figure 2.8 (b)), and caffeine (m/z 195; Figure
2.8 (c)) showed drift times of 0.90 ms (bin 20), 0.95 ms (bin 21) and 1.04 ms (bin 23)
respectively.   The selected ion responses are much cleaner and sharper then the total
ion mobility spectrum with peak widths at half height of  5 bins (ephedrine), 3 bins
(paracetamol) and 4 bins (caffeine) compared to 11 bins for the total ion mobility
spectrum.
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Figure 2.7  Ion mobility spectrum and selected ion mobility responses for the
DESI/IM-MS analysis of a generic cold and flu tablet obtained from a RP-TLC plate
without development, using DESI with a solvent composition of 50:50 (v/v)
acetonitrile:water with 0.1% formic acid at a flow rate of 25 µL/min. (a) m/z 168
(ephedrine), (b) m/z 152 (paracetamol), (c) m/z 195 (caffeine), and (d) total ion
mobility spectrum.
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The corresponding mass spectra are shown in Figure 2.8. The mass spectrum obtained
by combining all 200 bins (Figure 2.8 (d)) corresponds to the mass spectrum expected
in the absence of IM separation and contains a large number of desorbed ions across
the whole mass range. In contrast, when the mass spectra obtained by combining bins
at the drift times (bins 15-24, 18-23 and 21-25; Figure 2.8)  of the active ingredient
peaks (Figures 2.8(a), (b) and (c)) are compared to the mass spectrum from the
combined total ion mobility response, the enhanced selectivity for the actives is
observed. The resulting mass spectra show fewer ions and, in the case of paracetamol
(m/z 152) and caffeine (m/z 195), the [M+H]+ ion is the base peak.  Paracetamol was
the most abundant component in the cold and flu tablet (250 mg per tablet); however,
caffeine (25 mg per tablet) showed the highest IM-MS response, as a result of higher
DESI ionisation efficiency from the TLC plate.  On the basis of the amount of active
ingredient spotted on the plate the limit of detection (LOD) (3:1 signal-to-noise) was
estimated to be  16 µg/cm2, 34 µg/cm2 and  239 µg/cm2 for caffeine, ephedrine and
paracetamol respectively.  The amount spotted on the plate was determined by the
original concentration of the active ingredient in relation to the spot diameter.
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Figure 2.8 Mass spectra corresponding to selected ion mobility responses for the
DESI/IM-MS analysis of a generic cold and flu tablet obtained from a RP-TLC plate
without development (a) bins 15-24 (ephedrine), (b) bins 18-23 (paracetamol), (c)
bins 21-25 (caffeine), and, (d) mass spectrum obtained by combining all 200 bins
acquired during the ion mobility separation.
The total ion and selected ion mobility responses obtained from the DESI/IM-MS
analysis of paracetamol and codeine extracted from a generic Co-codamol tablet,
following separation by TLC, are displayed in Figures 2.9 and 2.10, together with an
image of the developed reversed-phase plate. The LODs were again estimated on the
basis of the amount spotted for both the active ingredients within the co-codamol
tablet.  Paracetamol was found to have a LOD of 225 µg/cm2 and codeine 9 µg/cm2.
The similar lower limit of detection for paracetamol following chromatographic
separation indicates that there is no significant ion suppression due to the presence of
excipient components in the undeveloped spot.  The drift time for paracetamol (Figure
2.8a)) was 0.90 ms (bin 20) showing good IM reproducibility for the RP-
TLC/DESI/IM-MS analysis of paracetamol (Figure 2.7b)). The sharp peak observed
in the m/z 152 selected ion response for paracetamol (Figure 2.9a)) contrasts with the
broad total ion mobility response when all 200 bins were averaged, shown in Figure
2.9b). The mass spectrum obtained by averaging the spectra in the range bin 19-23
(Figure 2.9(c)) has m/z 152 as the base peak. Comparing this spectrum with that
shown in Figure 2.9d), which is equivalent to the DESI-MS analysis without mobility
selection, demonstrates the effectiveness of the orthogonal IM and MS analysis in
simplifying and improving spectral quality.
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Analysis of the developed codeine spot also shows an increased selectivity for the
active ingredient. Figure 2.10 displays the total ion response and the selected ion
response for m/z 300, assigned to protonated codeine with a drift time of 2.3 ms.  The
corresponding mass spectra are shown in Figure 2.10(c) and (d). A comparison of the
mass spectrum corresponding to the codeine selected ion response with the total ion
response shows that the additional separation of ion mobility improves selectivity for
codeine.
It should be noted that the paracetamol (Figure 2.9(a)), and codeine (Figure 2.10(a)),
selected ion mobility responses were fully resolved by the ion mobility separation.
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Figure 2.9.  Ion mobility spectrum and selected ion mobility response for the
DESI/IM-MS analysis of a generic Co-codamol tablet obtained from a RP-TLC plate
following chromatographic development, using DESI with a solvent composition of
50:50 (v/v) acetonitrile:water with 0.1% formic acid at a flow rate of 20 µL/min. (a)
selected ion response for m/z 152 (paracetamol), (b) total ion mobility spectrum, (c)
mass spectrum corresponding to the selected ion response for m/z 152 (bins 19-23),
(d) mass spectrum obtained by combining all 200 bins acquired during the ion
mobility separation
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Figure 2.10.  Ion mobility spectrum and selected ion mobility response for the
DESI/IM-MS analysis of a generic Co-codamol tablet (conditions as Figure 2.4), (a)
selected ion response for m/z 300 (codeine), (b) total ion mobility spectrum, (c) mass
spectrum corresponding to the selected ion response for m/z 300 (bins 48-59), (d)
mass spectra corresponding to the total ion response.
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Method development experiments, although essential are often time consuming and
relatively expensive.  In this work, the solvent composition of the DESI spray was
varied by employing a step gradient to determine the optimum solvent for desorption.
Extracted Co-codamol was spotted onto the TLC plate, which was analysed
sequentially using three different solvent compositions (90:10, 50:50, 10:90,
acetonitrile:water with 0.1% formic acid).
Figure 2.11. RP-TLC/DESI/IM-MS analysis of an extracted Co-codamol tablet
employing a step gradient for the DESI analysis (90:10, 50:50, 10:90,
acetonitrile:water with 0.1% formic acid): signal response versus % organic solvent
for m/z 300  (codeine).
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Figure 2.11 shows signal response (m/z 300) versus % organic solvent.  Signal
responses were determined from the mass spectra corresponding to the selected ion
mobility response for codeine by combining bins across the peak at half height.  It can
be seen that the signal response for codeine increased signal response as the organic
component of the spray was reduced, which correlates with the high aqueous
solubility of codeine (1 g in 0.7 mL at 25 °C).  A greater % of water would facilitate
extraction of codeine from the surface of the TLC plate into the wetted surface layer.
Chemical imaging of the developed codeine spot was carried out by rastering across
the spot to obtain a 1-D image.  The DESI sampling stage was moved in increments
of 0.5 mm in the vertical plane to move the DESI plume across the spot and IM-MS
spectra were acquired and accumulated at each point.  Ion mobility spectra, consisting
of 200 mass spectra (bins), were averaged and the selected ion mobility response for
m/z 300 extracted from the data.
 The image obtained for the mass spectral ion intensity of m/z 300 at the drift time for
codeine, is displayed in Figure 2.12.  The codeine response for the TLC spot shows a
maximum intensity at 16 mm corresponding to the Rf of codeine (Rf = 0.16).  The 1-D
image allows peak areas to be calculated for quantitative analysis by DESI.
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Figure 2.12 RP-TLC/DESI/IM-MS selected ion response for scanned 1-D image,
showing signal distribution along a lane of the codeine TLC spot (m/z 300 and bin
53).  Line represents scan direction.
An alternative to a step gradient is a continuous gradient, Figure 2.13 displays an
online continuous gradient DESI-IM-MS analysis of paracetamol and
diphenhydramine spotted together on a non-bonded RP-TLC plate. A three minute
fast gradient was employed going from 0 to 100% methanol over 3 minutes. The
DESI sampling stage was moved in increments of 0.5 mm in the vertical plane to
move the DESI plume across the spot, ensuring that the analytes were not depleted
during the experiment. It can be seen that the two analytes desorb at different parts of
the gradient with the signal intensity for protonated paracetamol decreasing as the
percentage of organic increases and the protonated diphenhydramine molecule,
intensity increasing with the percentage of methanol (55-70% methanol).  The
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potential to enhance separation whilst reducing analysis and method development
times is shown.  The additional elution dimension of gradient DESI coupled to IM-
MS enhances the overall separation whilst overcoming the possibility of carry over of
the analytes normally associated with conventional LC systems.
Figure 2.13. RP-TLC/DESI-IM-MS analysis of extracted paracetamol from a  co-
codamol tablet and diphenhydramine from a generic sleepeaze tablet employing a
gradient for the DESI analysis.  Signal response versus % organic solvent for m/z 152
(paracetamol) and m/z 255 (diphenhydramine).
(min)
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2.5 CONCLUSION
Direct DESI/IM-MS analysis of pharmaceutical drug formulations has shown that this
approach may be rapidly employed to characterise and separate analytes of interest
from complex samples with little or no sample preparation. Ion mobility provided an
increase in selectivity for the active ingredient Loperamide in a tablet formulation by
improving spectral quality.  IM investigations also demonstrated the ability to
separate PDMS oligomers based upon their collision cross sections.
This study has further demonstrated that active pharmaceutical ingredients can be
desorbed by DESI directly from non-bonded RP-TLC plates, with or without
separation from the excipient components. Variation of the solvent composition of the
DESI spray using a step gradient allows the optimisation of the method for analytes
can be achieved with reduced development times. Continuous gradient RP-
TLC/DESI/IM-MS analysis shows the potential to further enhance separation whilst
reducing analysis and method development times.  The combined RP-TLC/DESI/IM-
MS approach has been shown to have potential to enhance selectivity for analytes
compared to DESI/MS alone.  Improved mass spectral quality was observed in all
cases when IM separation was used in conjunction with mass spectrometry as a result
of the orthogonal mobility and mass-to-charge separation.
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CHAPTER 3
The application of liquid chromatography-
ion mobility-mass spectrometry for the
metabonomic screening of rat urine.
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3.1 INTRODUCTION
IM is a separation technique that until recently has not been used in bioanalytical
applications, but preliminary studies have shown that using IM can aid the analysis of
small molecules in complex systems1 and IM-MS has proved to be a valuable tool for
proteomic research.2,3,4  The application of IM-MS using an atmospheric pressure drift
tube to the analysis of metabolic mixtures has recently been reported for extracts of
bacterial cell cultures (E. coli) infused directly into the ESI ion source of the
spectrometer.5 IM-MS analysis of the human glycourinome using pre-fractionated
urine has also been reported.6 These studies suggest that LC hyphenated with IM-MS,
may have potential for enhancing metabonomic studies without the requirement for
additional sample clean-up.  This chapter describes a preliminary evaluation of the
potential of LC-IM-MS using a low pressure IM drift cell for the analysis of the
urinary metabolome without prior extraction. Fast gradient reversed-phase liquid
chromatography was used for the rapid elution of endogonous metabolites, prior to
electrophoretic separation and m/z measurement by IM-MS.
FAIMS technology separates gas-phase ions at atmospheric pressure on the basis of
differences in their mobility under high field and low field conditions. This chapter
also describes the combination of FAIMS with ion trap mass spectrometry, using
electrospray ionisation (ESI), to afford gas-phase analyte characterisation based on
mass-to-charge (m/z) ratio and differential mobility (characteristic compensation
voltages (CV)). Selectivity offered by FAIMS-MS is exploited in this study for the
metabonomic analysis of rat urine using a cylindrical FAIMS configuration (Thermo
Fisher Scientific) combined with linear ion trap mass spectrometry. To overcome the
problems of coupling liquid chromatography (LC) to FAIMS resulting from the slow
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CV scan speed of the cylindrical FAIMS device, six compensation voltages in the
range -12V to -22 V were chosen to cover the range of metabolite differential
mobility. Metabonomics provides rich datasets for systems biology necessitating the
use of bioinformatics. In this study sample data sets were analysed using a stepwise
artificial neural network (ANNs) analysis to give rank orders of ions of interest for
each characteristic CV.  Principal component analysis was also carried out to test
reproducibility using quality control samples.
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3.2 CHAPTER THREE AIMS AND OBJECTIVES
The purpose of the work presented in this chapter was to explore novel methods for
the metabonomic study of urine employing drift tube ion mobility and FAIMS as an
additional separation technique to afford additional selectivity for analytes of interest.
The specific objectives were:
 To investigate the potential of drift tube IM combined with fast liquid
chromatography and mass spectrometry for the analysis of metabonomic
samples.
 To investigate the potential of FAIMS combined with fast liquid
chromatography and mass spectrometry for the analysis of metabonomic
samples.
 To carry out a full metabonomic investigation to distinguish age groups of rats
via the analysis of urinary profiles obtained by  LC-FAIMS-MS.
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3.3. EXPERIMENTAL
3.3.1 Chemicals
Methanol (HPLC grade), acetonitrile (HPLC gradient grade) and formic acid (99.5%
Puriss grade) were purchased from Thermo Fisher Scientific (Loughborough, UK).
Distilled and deionised water was obtained in-house using a Triple red water
purification system (Triple red, Long Crendon, UK).
3.3.2 IM-MS and LC-IM-MS analysis
All experiments were carried out employing a prototype IM-Q-TOF-MS (Waters
Corporation, Manchester), which is shown schematically in Figure 2.2 (Chapter 2)
Ions from the ESI source were directed into the trap region at the head of the ion
mobility drift cell, which was operated in the pressure region of 1.0 to 3.0 Torr N2.
Ions were gated into the drift cell using a gate electrode pulse (3.50 V, 200 µs pulse
width and 15 ms pulse period). The IM drift tube consisted of a multi-plate ion guide
(15.2 cm in length) to which a voltage gradient (14.24 V/cm and a supplement RF
voltage 3.8 V) were applied to facilitate separation of ion species by relative mobility.
Ions passing through the drift region were then directed into the reflectron TOF mass
analyses.  Ion mobility spectra were acquired by collecting data from 200 TOF pushes
(65 µs per bin) and plotting drift time (scan) against mass-to-charge ratio (m/z).  IM-
MS data were typically accumulated for 5 s, with a 2 s interscan delay. Initial studies
using direct introduction of urine samples into the IM-Q-TOF-MS spectrometer
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without chromatographic separation were performed by infusing the aliquots of the
prepared urine into the ESI ion source at 10 l/min using the integrated syringe pump.
Liquid chromatography was performed on a Waters Alliance 2790 chromatograph
(Waters Corporation, Manchester, UK) fitted with a Symmetry® (Waters
Corporation, Manchester, UK) C18 column (2.1 x 50 mm, 5 µm).  The LC system
was coupled to the ESI ion source of the IM-Q-TOF-MS spectrometer.  Urine samples
(50 µl injected) were eluted with the following gradient: 100% A (0-2 min), increased
to 100% B (2-5 min) and then to 100% A (5-8 min), where A = 0.1% aqueous formic
acid and B = 0.1% formic acid in acetonitrile. The mobile phase flow rate was set to
0.2 mL/min. Electrospray ionization conditions for the MS, with the ion source
operated in positive ion mode were: capillary voltage, 3.5 kV; cone voltage 60 V;
source temperature 120°C; desolvation gas, N2 gas flow 250 l/hr; desolvation gas
temperature, 180°C.   Masslynx version 4.1 (Waters Corporation, Manchester, UK)
was used to control the LC and IM-MS instrument and for data acquisition.  Data
mining was carried out using DriftScope version 1.0 (Waters Corporation,
Manchester, UK).
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3.3.3 LC-FAIMS-MS analysis
The FAIMS interface (Thermo Fisher Scientific, USA. Figure 1.3 (Chapter 1)) was
located between the ESI source and the linear ion trap mass spectrometer, LTQ
(Thermo Fischer Scientific, USA).  The FAIMS interface consists of inner and outer
cylindrical electrodes to which dispersion and compensation voltages are applied, is
shown schematically in Figure 1.4 and 1.5 (Chapter 1).
Liquid chromatography was performed on a Thermo Surveyor Liquid
chromatography system (Thermo Fisher Scientific, USA.) fitted with an Atlantis® T3
5 µm (2.5 x 50 mm) column (Waters Corporation, Manchester, UK). The LC system
was coupled to the ESI ion source of the FAIMS/LTQ spectrometer.  Urine samples
(20 µl injected) were eluted with the following fast gradient: 5% B increased to 20%
B (0- 0.5 min), held at 20% B (0.5-3.00 min), increased to 70% B (3.00-6.00), held at
70% B (6.00-8.00). Where A = 0.1% aqueous formic acid and B = 0.1% formic acid
in acetonitrile. Heated electrospray ionization conditions for the MS, with the ion
source operated in positive ion mode were: spray voltage: 5.5 kV, vaporizer
temperature 400 °C, sheath gas pressure (N2): 12 units, capillary voltage 25 kV,
capillary temperature 270 °C.  The FAIMS experimental conditions after optimisation
were dispersion voltage -5000 V, drift gas 50:50 mix of He and N2 at a flow rate of
3.75 L/min, outer bias voltage 25 V, inner electrode temperature 70 °C, outer
electrode temperature 90 °C. The compensation voltage was cycled between the
following values of, -12, -14, -16, -18, -20 and -22 V was selected. FAIMS
parameters and heated ESI source parameters are summarised in Table 3.1. Xcalibur
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2.0.7 (Thermo Fisher Scientific, USA) was used to control the LC, FAIMS and MS
system. Excel (2003, Microsoft corporation) was employed to construct mass-to-
charge tables for principal component analysis (PCA) and artifical neural network
analysis (ANNs). Spectra in each run were combined with the plotting style set to
stick, data was then converted to centroid data to provide spectra lists consisting of
m/z and ion intensity values. PCA and ANNs analysis was carried out by Andrew
Barnett and Professor Graham Ball of the Nottingham Trent University, Nottingham,
UK using Statistica version 8 (Statsoft).
Table 3.1 FAIMS and heated ESI source parameters including defined mass
parameters of the mass spectrometer.
FAIMS parameters Heated ESI probe Define mass parameters
Outer bias voltage: 25 V
Dispersion voltage :-5000 V
Inner electrode temperature: 70 °C
heater temp : 20 °C
sheath gas flow rate : 12 L/min
aux gas flow rate : 5 L/min
sweep gas flow rate : 0 L/min
spary volt : 5.5 kV
capillary temp : 270 °C
capillary voltage : 25 kV
tube lens : 100 V
mass range : normal
scan rate : normal
scan type : full
microscans : 1 s
max inject time :10 s
source fragmentation : off
first mass : 150 m/z
last mass : 2000 m/z
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3.3.3.1 Sample preparation
Urine samples from a group of rats (n=45) male Wistar-derived rats provided by
AstraZeneca (Alderley Park, Macclesfield, UK) were centrifuged at 13 000 rpm for 5
minutes to remove particulates and then frozen to -80°C prior to analysis. Aliquots of
each urine sample were combined to provide a pooled sample which was further split
to provide a multi-sample QC set. QC preparation consisted of firstly centrifuging the
urine samples, a 50 μL aliquot from each sample was then taken and pooled to give a
total volume of 3.45mL of quality control sample (50 uL x 69 = 3.45 mL).
Table 3.2 Urine sample information
* AP rats = Alderly Park (wistar-derived))
Number of samples Date Taken Rat Type Age
6 18:09:09 AP Rats * 4wks
6 19:09:09 AP Rats 4wks
6 02:10:09 AP Rats 6wks
6 16:10:09 AP Rats 8wks
6 30:10:09 AP Rats 10wks
5 13:11:09 AP Rats 12wks
5 27:11:09 AP Rats 14wks
5 11:02:09 AP Rats 16wks
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3.3.3.2 Sample run order and treatment
All samples were run in a random order with quality control samples (QC) to provide
a means of monitoring overall system and experimental performance.  QC samples
where run at the beginning, end and randomly throughout the experiment (randomise
via Excel, 2003 Microsoft corporation).  System conditioning consisted of 5 injections
prior to the first QC run as the first several runs have previously shown most variance
due to column and FAIMS equilibration. The sample run order was as shown in Table
3.3
Table 3.3 Randomisation and sample run order including; QC’s, blanks and
conditioning runs
Sample number Date taken Age Gender
Calibration check
Blank
conditioning
conditioning
conditioning
Conditioning
Conditioning
QC 1
25 30:10:09 10 wks M
30 30:10:09 10 wks M
22 16:10:09 8 wks M
45 11:02:09 16 wks M
35 13:11:09 12 wks M
12 19:09:09 4 wks M
Blank
QC 2
21 16:10:09 8 wks M
19 16:10:09 8 wks M
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9 19:09:09 4 wks M
5 18:09:09 4 wks M
41 11:02:09 16 wks M
16 02:10:09 6 wks M
Blank
QC 3
32 13:11:09 12 wks M
36 27:11:09 14 wks M
17 02:10:09 6 wks M
4 18:09:09 4 wks M
24 16:10:09 8 wks M
3 18:09:09 4 wks M
Blank
QC 5
1 18:09:09 4 wks M
40 27:11:09 14 wks M
37 27:11:09 14 wks M
6 18:09:09 4 wks M
29 30:10:09 10 wks M
15 02:10:09 6 wks M
Blank
QC 6
31 13:11:09 12 wks M
39 27:11:09 14 wks M
7 19:09:09 4 wks M
28 30:10:09 10 wks M
18 02:10:09 6 wks M
33 13:11:09 12 wks M
Blank
QC 7
42 11:02:09 16 wks M
23 16:10:09 8 wks M
27 30:10:09 10 wks M
20 16:10:09 8 wks M
8 19:09:09 4 wks M
43 11:02:09 16 wks M
Blank
QC 8
44 11:02:09 16 wks M
11 19:09:09 4 wks M
2 18:09:09 4 wks M
26 30:10:09 10 wks M
14 02:10:09 6 wks M
13 02:10:09 6 wks M
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Blank
QC 9
34 13:11:09 12 wks M
10 19:09:09 4 wks M
38 27:11:09 14 wks M
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3.4 RESULTS AND DISCUSSION
3.4.1 An approach to enhancing coverage of the urinary metabonome using
liquid chromatography-ion mobility-mass spectrometry
Initial experiments were carried out by directly infusing aliquots of urine into the ESI-
IM-Q-TOF-MS spectrometer as described in the experimental section, pages 104-105.
However, the salt component of the urine caused significant ion suppression in the
electrospray ion source (data not shown) and hence liquid chromatography was
employed to reduce these suppression effects.  The urinary metabolic profile is
composed mainly of relatively polar/ionic substances, which must be retained on the
LC column whilst the salts elute prior to mass spectrometry analysis. In order to
obtain the best possible retention of these polar metabolites, we therefore used a
gradient separation where the initial segment (0-2 min) was entirely aqueous formic
acid, followed by a rapid increase (over 5 min) to 100% acetonitrile. The
effectiveness of the LC column for improving spectral quality is shown in the LC-
ESI-IM-MS data for a pooled urine sample obtained from the Wistar-derived rats,
shown in Figure 3.1.  The peaks in the LC chromatogram correspond to the IM
spectra accumulated during the LC run (Figure 3.1(a)). The salt component was eluted
in less than 1 minute (Figure 3.1 (a)) showing ion suppression effects and an
increased noise in the mass spectrum (Figure 3.1 (b)), leaving the metabolites and
other components of the urine to be eluted in the region 3-8 minutes, free from salt
interferences (Figure 3.1(c)).
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Figure 3.1 (a) LC chromatogram showing accumulated IM spectra derived from the
LC-IM-MS analysis of urine obtained from male Wistar-derived rats, (b) mass
spectrum corresponding to retention time window 1.0 – 1.3 min, (c) mass spectrum
corresponding to retention window 5.5 – 6.0 min.
The effect of introducing an IM separation in tandem with LC and MS analysis of
urinary metabolites is shown in Figure 3.2. In this experiment, data were acquired as
nested data sets, with mass spectra (65 s/scan) and IM spectra (~13 ms) scanned
repetitively throughout the LC run. Spectra were accumulated to yield 200 mass
spectra and one ion mobility spectrum every 7 s. The ion mobility drift time is plotted
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as ‘bins’, where each bin corresponds to an acquired mass spectrum. The nested data
acquisition of IM and MS data results in an analysis incorporating a gas-phase
electrophoretic separation of the ESI generated ions on the basis of charge state and
collision cross section (i.e. size and shape), between the reversed-phase
chromatography and mass analysis, all within the timescale of the LC-MS run (Figure
3.2(a)). IM has a relatively poor resolving power, with a typical full width at half
height (FWHH) resolution of 10, corresponding to ~500 theoretical plates in total.
However, peak capacity is increased in LC-IM-MS, because the IM separation is
orthogonal to that of LC retention and mass-to-charge ratio.
The mass spectrum shown in Figure 3.2(b) was generated by summing all 200 mass
spectra in each IM scan and is therefore equivalent to the mass spectrum for LC-MS
analysis without IM separation. Figure 3.2(c) shows the IM spectrum summed over all
m/z values and corresponds to LC-IM analysis without mass separation. The enhanced
separation afforded by the combined IM-MS analysis is shown in the 2-D plot of ion
drift time (bins) vs m/z, which is presented in Figure 3.2(d) for data averaged over the
whole LC run (0-7 min). The bands of colour reflect the intensity of the ions with red
representing the highest intensity and blue/white the lowest intensity.
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Figure 3.2 LC-IM-MS analysis of urine obtained from male Wistar-derived rats, (a)
LC chromatogram, (b) the  mass spectrum generated by summing all 200 mass spectra
in each IM scan during the LC run, (c) total ion mobility spectrum summed over all
m/z values, (d) 2D plot of drift time (bins) versus m/z plot for the full data set.
Analysing these multidimensional LC-IM-MS data sets presents a challenge for
multivariate statistical techniques commonly used in comparative metabonomics,
since conventional statistical theory requires at least twice as many sample replicates
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as the number of dimensions in the data. Advanced bioinformatic techniques are
required, such as artificial neural networks, which are capable of handling complex,
multidimensional and non-linear data sets.7 An alternative approach is to reduce the
complexity of the data by selecting retention time or drift time windows for analysis,
or by other pre-treatment strategies.8 A retention time region (3.6 – 3.9 min) from the
LC run was selected because of the many metabolites eluting in this time window and
Figure 3.3 shows the IM-MS data associated with this region.
Figure 3.3 (a) Drift time (bins) versus m/z plot of selected retention window 3.6-3.9
minutes derived from the LC-IM-MS analysis of rat urine, (b) total ion mobility
spectrum corresponding to retention time window 3.6-3.9 minutes, (c) mass spectrum
corresponding to total ion mobility spectrum of retention time window 3.6-3.9
minutes.
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 There is a significant reduction in background noise (indicated by an increase in
blue/white shading) and an overall simplification of the drift time vs m/z analytical
space. The IM and MS spectra shown in Figure 3.3(b) and 3.3(c) were obtained by
averaging the drift time and m/z data shown in Figure 3.3(a). The resulting spectra
(Figure 3.3(b) and 3.3(c)) therefore correspond to those expected for LC-IM (Figure
3.3 (b)) and LC-MS (Figure 3.3(c)) separations respectively.
Figure 3.4  (a) Extracted ion chromatogram (XIC) for m/z 162.1 obtained from the
LC-IM-MS analysis of male Wistar-derived rat urine, (b) selected ion mobility
spectrum of m/z 162.1, corresponding to the selected retention time window 3.6-3.9
min, (c) mass spectrum corresponding to selected ion mobility spectrum for m/z 162.1
(IM bins 20-25 combined).
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It is possible to enhance selectivity for target analytes by utilising the orthogonal
separation of the LC, IM and MS dimensions. This is illustrated in Figure 3.4 for the
m/z 162.1 ion, assigned to the endogenous metabolite carnitine (C7H15NO3)9.  The
extracted ion chromatogram for this ion is shown in Figure 3.4(a). The ion intensity
reaches a maximum at a retention time of 3.8 min and the selected ion mobility
response for the m/z 162.1 ion in the ion mobility spectra acquired in the retention
time window 3.6 – 3.9 min is shown in Figure 3.4(b).  The sharp peak observed in the
drift time region corresponding to bins 20-25 contrasts with broad total ion mobility
response observed in the same retention time window when all 200 bins were
averaged, seen in Figure 3.3(b). The mass spectrum obtained by averaging the spectra
in the region 20-25 bins (Figure 3.4(c)) has m/z 162 as the base peak. Comparing this
spectrum with that shown in Figure 3.3(c), which is equivalent to the LC-MS analysis
without mobility selection, demonstrates the effectiveness of the orthogonal LC, IM
and MS analysis in simplifying and improving spectral quality. Confidence in the
assignment of targeted or unknown species is increased by the presence of an ion of
the correct m/z at the expected IM drift time and the LC retention time associated with
a metabolite.
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3.4.2 Metabonomic screening of rat urine using high field asymmetric waveform
ion mobility spectrometry combined with liquid chromatography-linear ion trap
mass spectrometry
Optimisation of the FAIMS system was initially carried out to ensure that the filtering
effect of the FAIMS was utilised allowing the removal of interferences, whilst
maintaining optimum ion transmission of the analytes of interest. Due to the slow CV
scan speed of the FAIMS separation it was not possible to scan the FAIMS spectrum
(> 1min for full CV range) within the time scale of a typical chromatography peak.
Experiments therefore, consisted of injections of urine through the LC-FAIMS-MS
system at fixed CV values. The CV range where most urinary analytes where
transmitted to the MS was found to be -12 to -22 V. Six fixed CV values were chosen;
-12.0, -14.0, -16.0, -18.0, -20.0 and -22.0 and the FAIMS device was set to cycle
between these values throughout the experiment ensuring all separations were
conducted within the time limit of a single chromatography peak. Further experiments
were carried out to determine the experimental conditions for the both the FAIMS and
MS system to ensure optimum signal intensity and transmission.  Validation
experiments consisted of six urine injections (after column and system conditioning)
with four ions selected across the m/z range (m/z 104.1, 118.2, 175.2, 309.3). Ion
intensities for these ions over the six runs were recorded and compared. A decrease in
ion intensity was observed as the FAIMS front plate became increasingly
contaminated, but an increase in the desolvation flow rate significantly improved the
stability of the ion intensities. % Relative standard deviations of the ion intensities m/z
104.1, 118.2, 175.2, 309.3 were 112.5, 37.5, 62.5 and 35 % respectively showing
reasonable reproducibility. A FAIMS acceptance test was carried out before the start
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of experiments ensuring the FAIMS device was producing acceptable CV values for
known ions, Caffeine, m/z 195 (CV range -5 to -10), ultramark, m/z 524 (CV range -
20 to -28) and MRFA, m/z 1522 (CV range -10 to -16) recorded CV values of -8.47,
-21.71, and -11.87 respectively.
In order to obtain the best possible retention of polar metabolites, a gradient
separation was employed where the initial segment (0-2 min) was entirely aqueous
formic acid, followed by a rapid increase (over 5min) to 100% acetonitrile. The
effectiveness of the LC column for improving spectral quality was previously shown
in Figure 3.1.  The LC separation further enhances the overall analysis by reducing
the number of coeluting analytes entering the FAIMS -mass spectrometer ion source,
hence reducing ion suppression. Sample responses can depend on the sample run
order, as the source of the mass spectrometer becomes contaminated over time
leading to sensitivity changes.  Randomisation of the sample run order was used to
ensure that all the experimental samples and subsequent statistical analysis of the data
did not show systematic bias. All experimental samples were randomised throughout
and the sample run order is displayed in (Table 3.2.)  A further challenge as discussed
above is the potential for the analytical system to change with time. A number of
approaches have been suggested to ensure that the results obtained are valid and, in
this study, the use of quality control samples (QCs) was employed. The QCs consisted
of a pooled urine sample prepared, by taking aliquots of the samples to be analysed as
previously discussed, section 3.3.3.1.
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The fractionation of the rat urinary metabonome afforded by FAIMS can be seen in
Figure 3.5. Different ions are detected at the different CV values showing the
potential to increase the available analytical space via FAIMS analytes of separation.
Three of the six CV values are displayed ( -12, -18 and -22). In each mass spectrum a
different base peak and overall ion compliment is seen, with base peaks of m/z 76,
231 and 187 for CVs -22, -18 and -12 respectively.
Figure 3.5 LC-FAIMS-MS analysis of rat urine.  Mass spectra showing three selected
compensation voltage values (a) -22 (b) -18 and (C) -12.
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It is possible to enhance selectivity for target analytes by utilizing the orthogonal
separation of the LC, IM and MS dimesions.  This is shown in Figure 3.6 for the m/z
309 ion. The total FAIMS mass spectrum obtained by combining mass spectral data
from all six CV scans in the FAIMS run is displayed in Figure 3.6(a), which is
equivalent to the LC/MS analysis without FAIMS selection and shows a large number
of ions.  In contrast, when the mass spectrum obtained by selecting a retention time
3.56 min and CV value of -16V (Figure 3.6 (b)) is compared with the total FAIMS
spectrum, enhanced selectivity for m/z 309 is achieved with the selected m/z 309 as
the base peak. Overall the spectral simplification and reduction in background noise
demonstrated the effectiveness of the orthogonal LC, FAIMS and MS analysis for
improving spectral quality for targeted analytes.
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Figure 3.6 (a) Mass spectra corresponding to total FAIMS spectrum derived from the
analysis of rat urine employing LC-FAIMS-MS generated by combining all cv values
and (b) mass spectrum corresponding to selected CV value of -16V and a retention
time 3.54 min.
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The study of metabonomics depends on the generation of global metabolite profiles
and by recording changes in the concentrations of low molecular weight metabolites.
Such investigations generate large volumes of data. Data mining methods are
therefore required to obtain insights into biological processes such as ageing. During
this metabonomic study of rat urine, Statistica version 8 (Statsoft) was employed for
data analysis.
The ability to demonstrate that metabonomic data is of high quality is crucial if
studies are to provide biological insights into the processes of development, disease
and toxicity. Demonstrating that variability of metabonomic data generated is within
acceptable limits is essential, the use of quality control samples to define the
reproducibility of data with quality control measures was required at all stages of the
analytical process.  To test reproducibility, preliminary statistical analysis of a
biological QC sample data set by principal component analysis (PCA) was employed
to assess the stability of the analytical method. If all QC samples group then the
system is stable. QC samples were generated as described in section 3.3.3.1 to provide
a representative mean sample containing all the analytes that will be encountered
during the analysis.
 Figure 3.7 shows the PCA results with QC samples 1 to 4 indicating good
reproducibility. However, QC 5-6 did not show characteristic clustering compared to
QC 1 to 4. The instrumental response appears to have drifted towards the end of the
experiment with QC samples 5 and 6 showing drift away from the other QCs,
indicating that as the experiment progresses the reproducibility decreases. A possible
explanation is the effect of contamination of the FAIMS device over time reducing
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the signal intensity and the compliment of ions transferred into the FAIMS device.
The clustering of the main group of QCs suggests the majority of the data is valid and
worth further study. Artificial neural networks (ANNs) was employed for data
analysis. Both the PCA and ANN analysis was carried out by Andrew Barnett and
Professor Graham Ball of the Nottingham Trent University, UK. Artificial neural
networks are a form of machine learning from the field of artificial intelligence with
proven pattern recognition capabilities and have been utilized in many areas of
bioinformatics. This is due to their ability to cope with highly dimensional complex
datasets such as those developed by protein mass spectrometry and DNA microarray
experiments. As such, neural networks have been applied to problems such as disease
classification and identification of biomarkers10.
.
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Figure 3.7 Principal Component Analysis of the quality control samples (a) PCA
score plot of PC1 vs. PC2 and (b) plot of variance for the PCA analysis.
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Due to the volume and complexity of the data generated, statistical analysis was
carried out employing an ANNs, a step-wise approach to produce a rank order of ions
for each compensation value. In most cases, ANN is an adaptive system that changes
its structure based on external or internal information that flows through the network
during the learning phase. Modern neural networks are non-linear statistical data
modeling tools. They are usually used to model complex relationships between inputs
and outputs or to find patterns in data11.  In this study the ANNs was employed to
distinguish between young and old rats based on their urinary profile and to determine
which compensation value is most discriminatory and which ions provide the
discrimination to determine age groups from urinary profiles.
Figure 3.8. ANN statistical analysis of LC-FAIMS-MS analysis of rat urine: Plot of
averaged error for each compensation voltage
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A plot of test error vs distinguishing ion is shown in Figure 3.8. The steepness of the
line show in Figure 3.8 determines how many distinguishing ions are present to
distinguish old from young rats based upon their urinary profiles and the level to
which they distinguish, the steeper the range within the test error the more distinction
is possible. It can be seen that 4 predominate ions are identified in Figure 3.8 to
provide a distinction between old and young rats from their urinary profiles. Further
analysis searched for commonalities in adjacent compensation values. It can be seen
that four predominant ions are identified in Figure 3.8, which provide a distinction
between old and young rats from their urinary profiles. The highest ranked ion had an
RMS error of 0.162. This model predicted 83.8% of cases correctly. The most
discriminatory CV and m/z values for distinguishing age based on urinary profiles
were -18 V and m/z 278 respectively.
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3.5. CONCLUSION
This study demonstrates that nested LC-IM-MS data may be acquired on directly
injected urine samples within the timescale of an LC-MS experiment. The combined
LC-IM-MS approach has the potential to enhance the metabonomic coverage by the
introduction of a gas-phase electrophoretic separation that is orthogonal to the
reversed-phase LC and mass-to-charge MS separations. Data mining for the detection
of a targeted analyte is also demonstrated yielding improved spectral quality and
confidence in assignment.
This study has further demonstrated that the combined LC-FAIMS-MS approach has
the potential to enhance selectivity and improve mass spectral quality for analytes of
interest compared to LC-MS alone. Preliminary statistical analysis of data from a LC-
FAIMS-MS analysis of rat urine samples has shown the use of QC data analysis with
rank ordering of ions allowing 84% of young and old rats to be distinguished from
each other.
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CHAPTER FOUR
Real-time reaction monitoring using
ion mobility-mass spectrometry
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4.1 INTRODUCTION
Process understanding and validation is an essential requirement for process control,
to assure quality and purity in the manufacture of chemicals and pharmaceuticals. The
Food and Drug Administration (FDA) has recognised that process knowledge is key
to quality and, through better understanding, to building a cause and effect model that
improves process control1. The pharmaceutical industry also requires quick, efficient,
sensitive and high throughput methods for both quality control and quality assurance
of drug products. Real-time reaction monitoring can provide detailed information
about the course of a reaction and in turn aid process understanding. Current
techniques employed for real-time reaction monitoring include, liquid
chromatography (LC)2, mass spectrometry,3 infrared spectroscopy,4 nuclear magnetic
resonance spectroscopy5 and near infrared spectrometry6 However, there is a need to
develop new approaches for real-time reaction monitoring that provide enhanced
quantitative and structural information on reaction intermediates and products.
The combination of ion mobility spectrometry with mass spectrometry (IM-MS)
allows gas-phase ions generated in an electrospray ion source to be separated first by
their ion mobility in a drift cell and then by mass-to-charge ratio in the mass analyser.
The technique also lends itself to the acquisition of nested data sets, in which MS
spectra are acquired at regular intervals (45-60 µs) during each IM separation (~15
ms), thereby reducing analysis times whilst having the potential to improve selectivity
and data quality compared to MS analysis alone.7
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IM has evolved into a technique for sensitive detection of many trace compounds and
a wide range of chemical species such as chemical warfare agents,8 biomolecules,9
drugs of abuse10 and inorganic substances.11 IM has also been reported for the online
monitoring of monomer concentrations in (semi-) batch emulsion polymerisation
reactors,12 the monitoring of yeast fermentation,13 part per billion level process
monitoring of ammonia in process streams14 thus indicating the potential of IM as a
rapid and precise measurement device for the monitoring of processes. More recently
IM has been reported in pharmaceutical applications ranging from cleaning
verification of manufacturing equipment,15 direct formulation analysis16 and
protection of pharmaceutical workers health and safety.17 These studies suggest that
IM combined with MS, may have potential for enhancing pharmaceutical process
understanding and process control.
.
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4.2 CHAPTER FOUR AIMS AND OBJECTIVES
In this chapter, demonstrating proof of principle for the use of IM-MS for reaction
monitoring applied to the direct, real-time analysis of the products formed when 7-
fluoro-6-hydroxy-2-methylindole is deprotonated by sodium hydroxide was shown.
The use of orthogonal IM and MS analysis yields data comparable to mass
spectrometry alone, but with the addition of an ion mobility dimension.
The specific objectives were:
 To investigate the potential of IM-MS for reaction monitoring studies to
increase selectivity and separate analytes of interest with little or no sample
preparation.
 Improve understanding of reaction monitoring processes to aid pharmaceutical
development.
 The comparison of IM-MS and MS for reaction monitoring studies and to
evaluate the potential of IM as a pre-separation technique for gas phase ions.
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4.3 EXPERIMENTAL
4.3.1 Chemicals
Acetonitrile (HPLC gradient grade) and water (HPLC grade) were purchased from
Thermo Fisher Scientific (Loughborough, UK) Mass spectrometry grade (puriss, p.a)
formic acid and sodium hydroxide (ACS reagent, ≥ 97.0%) pellets were purchased
from Sigma-Aldrich (Gillingham, UK). 7-fluoro-6-hydroxy-2-methylindole was
provided by AstraZeneca (Macclesfield, UK).
4.3.2 Sample preparation and real time monitoring
Stock solutions of 7-fluoro-6-hydroxy-2-methylindole were prepared at
concentrations of 0.1, 1, 3, 5, 10, 15, 20 and 50 µg/mL in 49.5/49.5/1 (v/v/v)
acetonitrile/water/formic acid for calibration procedures.
7-fluoro-6-hydroxy-2-methylindole (125 µg/mL) was prepared in acetonitrile and
stirred for 10 minutes on ice. Aqueous sodium hydroxide (40 m moles) was prepared
in deionized water and added to the indole reaction vessel over a two minute period to
initiate the deprotonation reaction. The reaction vessel was maintained at a
temperature between -5 and 0 °C for the first six hours of the reaction, after which the
reaction vessel was left overnight to warm to room temperature. Aliquots (20 µl) of
the reaction mixture were removed from the reaction vessel and diluted to a
concentration within the linear dynamic range of the analysis in 49.5/49.5/1 (v/v/v)
acetonitrile/water/formic acid to quench the reaction for IM-MS analysis and infused
into the ESI source at 5 µl min-1. For real-time reaction monitoring, spectra were
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recorded at regular intervals during the deprotonation of the indole. Thus, a time zero
spectrum was acquired before the addition of the sodium hydroxide and further
spectra were acquired at  60, 80, 160, 220 minutes and 24 hr and 7 days after addition
of the sodium hydroxide.
4.3.3 Instrumentation
Direct infusion IM–MS experiments were performed on a Synapt HDMS
spectrometer (Waters Corporation, Manchester, UK), operated in positive ion mode
with the ESI capillary voltage set to 3 kV and the cone voltage to 27 V. The nitrogen
desolvation and cone gas flow rates were set to 500 and 30 L h−1 respectively, with a
source temperature of 120 °C and desolvation gas temperature set to 300 °C. The ion
mobility region contains three (trap, IM, and transfer) travelling wave stacked ion
guides (TWIGS). The trap ion guide was used to accumulate ions and periodically
then release an ion packet into the IM ion guide for mobility separation. A full
description of the mode of operation of stacked ring ion guides with travelling waves
is given elsewhere.18 The travelling wave velocity was set to 300 ms−1 with a pulse
height of 12 V in all acquisitions. Ions were injected into the IM TWIG from the trap
TWIG for 200 μs in every ion mobility separation. Each ion mobility spectrum
consists of 200 sequential ToF mass spectra (acquisition time typically less than
15 ms). The quadrupole was operated in wide band pass mode (m/z 50-1000) and the
collision cell contained no collision gas. IM–MS data were obtained by combining the
ion mobility spectra acquired in a 120 s infusion. Acquired data were presented as a
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plot of time against ion signal intensity; total ion mobility response or selected ion
mobility responses. Masslynx version 4.1 software (Waters corporation, Manchester,
UK) was used to control the IM-MS instrument and for data acquisition. Data mining
was carried out using DriftScope version 2 (Waters corporation, Manchester, UK).
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4.4 RESULTS AND DISCUSSION
7-fluoro-6-hydroxy-2-methylindole (I) is converted to the O-linked indole product, 4-
[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-2-methyl-1H-indol-5-ol (II), in the presence
of air and sunlight, and through the addition of aqueous sodium hydroxide. Further
deprotonation of II by the sodium hydroxide leads to the formation of higher O-linked
polymeric products, resulting in an increase in sample complexity over time.
Improved understanding of these processes is required for pharmaceutical
development. Reaction monitoring was carried out by IM-MS and MS with
electrospray ionization, to follow the rate of polymerization of the indole I to II and
other O-linked products (Figure 4.1), generating mass-to-charge and mobility data for
the analyte ions present in the reaction mixture.
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Figure 4.1 Schematic representation of the polymerization of indole I to II and other
O-linked products.
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138
Initial investigations were directed at the optimization of the composition of the
solvent system used to quench the aliquots of reaction mixture extracted from the
reaction vessel for analysis. Three solvent systems were investigated: 100 %
acetonitrile (ACN), 50/50 (v/v) ACN/water and 49.5/49.5/1 (v/v/v)
ACN/water/formic acid.  Experiments carried out in 100 % ACN, gave a low signal
response for all ions, with a total ion mobility response ion count approximately an
order of magnitude less than the 50/50 (v/v) ACN/water and ~30 times less than the
49.5/49.5/1 (v/v/v) ACN/water/formic acid solvent system, for an initial indole
concentration of 2.5 µg/mL.  The presence of formic acid quenches the base catalysed
reaction and enhances ionization efficiency, so 49.5/49.5/1 (v/v/v) ACN/water/formic
acid was used for reaction monitoring with spectral acquisition carried out
immediately after sample dilution.
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Figure 4.2. Calibration curve for the IM-MS analysis of indole.
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MS Indole calibration
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Figure 4.3. Calibration curve for the MS analysis of indole
Calibration curves were created from the indole standards for both IM-MS (Figure
4.2) and MS analysis (Figure 4.3).  IM-MS analysis has a lower linear dynamic range
than MS because of detector saturation, but the analysis of the calibration standards
showed a linear response in the concentration range 0.1 - 5 µg/mL for the indole, with
an R2 value of 0.9941. The MS analysis showed a linear response in the
concentration range 0.1-6 μg/mL for the indole, with an R2 value of 0.9912. To ensure
experiments were carried out within the linear dynamic range of the instrument,
sample aliquots removed from the reaction vessel were diluted to a concentration
within the linear dynamic range for the analysis. IM-MS data were acquired by
repetitive scanning of nested data sets, with mass spectra (45 µs/scan) and IM spectra
(~13 ms) scanned repetitively throughout, spectra were accumulated to yield 200
Concentration
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mass spectra and one IM spectrum every 7 seconds. The IM drift time is plotted as
‘bins’, where each bin corresponds to an acquired mass spectrum.
The total ion and selected ion mobility responses for the IM-MS analysis of the indole
reaction mixture one hour after addition of aqueous sodium hydroxide are displayed
in Figure 4.4.
Figure 4.4 Ion mobility spectra for the IM-MS analysis of 7-fluoro-6-hydroxy-2-
methylindole reaction mixture: (a) total ion mobility spectrum, (b) selected ion
mobility response for m/z 311 (protonated indole II)
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The selected ion response for the protonated indole, II (m/z 311.13; Figure. 4.4(b)),
shows a sharp peak, compared to the total ion mobility response, which is centered at
a drift time of 5.72 ms and has a peak width at half height of 25 bins.  The
corresponding mass spectra are shown in Figure 4.5.
 The mass spectrum obtained by combining all 200 bins (Figure 4.5(a)) corresponds to
the spectrum expected in the absence of IM separation and contains a large number of
ions across the whole mass range.  In contrast, when the mass spectrum obtained in
IM-MS mode by combining bins 128-130 (drift time range 5.7-5.8 ms; Figure. 4.5(b))
is compared with the mass spectrum in the absence of ion mobility separation, the
relative intensity of the [M+H]+ ion for II (m/z 311.13) has been enhanced selectively
and is observed as the base peak in the ion mobility-selected mass spectrum.
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Figure 4.5 Mass spectra for the IM-MS analysis of 7-fluoro-6-hydroxy-2-
methylindole reaction mixture: (a) mass spectrum obtained by combining all 200 bins
acquired during the ion mobility separation and (b) mass spectrum corresponding to
the mobility-selected ion response for m/z 311 (bins 128-130; drift time range 5.7-5.8
ms)
The complexity of the reaction mixture one hour after addition of sodium hydroxide is
illustrated in Figure 4.6, which shows the m/z versus ion drift time (bins) space,
averaged over the whole IM-MS analysis, allowing good visualisation of the full IM-
MS analysis data. The protonated monomer (I), O-linked product (II) and O-linked
trimer ions are highlighted showing that these ions are resolved on the basis of mass-
to-charge and drift time.
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Figure 4.6 2D plot of drift time (bins) vs m/z for full data set of IM-MS analysis of
indole reaction mixture, one hour after addition of aqueous sodium hydroxide, (a)
indole monomer (m/z 166, I), (b) O-linked dimer (m/z 311, II) and (c) O-linked trimer
(m/z 456).
The drift time of an ion may be used to determine the collision cross section which
may be correlated with modelled or predicted structures19,20,21 so IM-MS data has the
potential for the structural analysis of mass-selected transient intermediates and
products in complex reaction mixtures for enhanced process understanding.
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The indole reaction mixture was monitored by MS and IM-MS over a period of seven
days. The reaction of indole monomer (I, m/z 166) to O-linked dimer (II, m/z 311)
following addition of aqueous sodium hydroxide was fast, indicated by the reaction
mixture rapidly turning from a straw coloured to a dark brown solution. The reaction
continues via further addition of indole phenolate, with elimination of fluorine, to
produce higher polymeric products.
Figure 4.7 displays the time dependent ion intensities for the protonated ions derived
from the reactant and products under MS and IM-MS analysis: m/z 166 (monomer, I),
m/z 311 (O-linked dimer, II), m/z 456 (O-linked trimer), m/z 601 (O-linked tetramer),
m/z 746 (O-linked pentamer) and m/z 891 (O-linked hexamer).
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Figure 4.7 MS and IM-MS analysis of the reaction of 7-fluoro-6-hydroxy-2-
methylindole following the addition of aqueous sodium hydroxide. (a) signal response
versus time in minutes for m/z 166 (monomer, I), m/z 311 (O-linked dimer, II), m/z
456 (O-linked trimer), m/z 601 (O-linked tetramer), m/z 746 (O-linked pentamer) and
m/z 891 (O-linked hexamer) using (a) MS and (b) IM-MS.
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Products and reactants ions were observed under both MS and IM-MS conditions.
The ion intensities were lower in IM-MS mode, because of the transmission
efficiency through the IM drift cell, but the instrumental sensitivity was sufficient for
monitoring reactant and products throughout the course of the reaction. Ion counts
were generated by combining selected bins (mass spectra) from the ion responses for
each ion of interest at half height across the mobility peak.  The O-linked dimer
formation quickly reached a maximum intensity after the addition of sodium
hydroxide and decreased thereafter as seen in Figure 4.7. The decrease in dimer ion
intensity was associated with further polymerisation to form higher multimers. The
formation of O-linked trimer reached a maximum at the same time as the dimer, but
ion intensity showed only a slow decline during the first 80 minutes, followed
thereafter by a sharper decline. The O-linked tetramer, pentamer and hexamer ion
intensities rose more slowly, with the tetramer reaching an ion count maximum after
60-80 minutes in both the MS and IM-MS modes.  The total ion current for all ions
summed falls with time reflecting the difference in mass spectrometric response
between the O-linked multimers and the monomer. These data suggest that the
monomer was progressively converted to the higher oligomers over time. The close
similarity of the ion intensity trends observed in both the MS and IM-MS modes
demonstrates that no loss of information is observed in IM-MS mode, whilst the
greater selectivity and potential for structural analysis that IM measurement brings to
the analysis has the potential to enhance ion assignments and process understanding.
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4.5 CONCLUSION
This study has demonstrated that ion mobility-mass spectrometry can be employed as
a rapid means to analyse a model chemical reaction mixture, offering the potential for
real time reaction monitoring. The IM-MS approach has been shown to have potential
to enhance visualization of the data selectivity for analytes compared with MS alone,
as a direct result of the orthogonal mobility and mass-to-charge separation.
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CHAPTER FIVE
Conclusions & Further Work
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5.1 CONCLUSIONS TO THESIS & FURTHER WORK
The research presented in this thesis describes the development of IMS in
combination with other analytical techniques for the high-throughput analysis of
complex samples. The combination of ion mobility spectrometry with mass
spectrometry (IM-MS), allows gas-phase ions generated in either the ESI or DESI ion
source to be separated first by their mobility in a drift cell and then by mass-to-charge
ratio in the mass analyser, providing a multidimensional separation with improved
selectivity for the analytes of interest.
Chapter 2 describes the direct, rapid analysis of pharmaceutical drug formulations and
active ingredients employing DESI-IM-MS. The direct analysis of Imodium plus
caplets, containing active ingredients loperamide (2 mg) and simethicone (containing
an equivalent to 125 mg of poly(dimethyl siloxane) (PDMS) was investigated. Ion
mobility provided an increase in selectivity for the active ingredient Loperamide in a
tablet formulation.  IM investigations also demonstrated the ability to separate PDMS
oligomers based upon their collision cross sections.
Further studies investigated the direct analysis of pharmaceutical formulations and
active ingredients from non-bonded reversed-phase thin layer chromatography (RP-
TLC) plates by desorption electrospray ionisation (DESI) combined with IM-MS.
The analysis of formulations containing analgesic (paracetamol), decongestant
(ephedrine), opiate (codeine) and stimulant (caffeine) active pharmaceutical
ingredients was carried out with, and without, chromatographic development to
separate the active ingredients from the excipient formulation.  Spectral quality was
enhanced by combining ion mobility and mass spectrometry. Variation of the solvent
composition of the DESI spray using a step gradient allows the optimisation of the
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conditions for analytes with reduced method development times. The use of a
continuous DESI solvent gradient in the RP-TLC/DESI/IM-MS analysis allows
selective desorption of active pharmaceutical ingredients from the surface of the TLC
plate,whilst reducing analysis times. The combined RP-TLC/DESI/IM-MS approach
has potential as a rapid and selective technique for pharmaceutical analysis by
orthogonal gas-phase electrophoretic and mass-to-charge separation.  Further work to
investigate the potential of on-line variation of the DESI solvent spray could be
explored to provide  direct pre-fractionation of complex samples, or matrix clean-up,
equivalent to an SPE procedure with minimum sample preparation for a variety of
analytes. The application of RP-TLC/DESI/IM-MS could be employed to desalt
complex from biological samples, such as urine, without the need for liquid
chromatography separation. The  potential for DESI imaging has been demonstrated
and further investigations  could be directed towards the  fast metabonomic analysis
of intact tissue samples.
Chapter 3 shows the potential of drift tube ion mobility (IM) spectrometry in
combination with high performance liquid chromatography (LC) and mass
spectrometry (MS) for the metabonomic analysis of rat urine. The combined LC-IM-
MS approach using quadrupole/time-of-flight mass spectrometry with electrospray
ionisation, uses gas-phase analyte characterisation based on both m/z and relative gas-
phase mobility following LC separation. The technique allowed the acquisition of
nested data sets, with mass spectra acquired at regular intervals (65 s) during each
IMS separation (~13 ms) and several IMS spectra acquired during the elution of a
single LC peak, without increasing the overall analysis time compared to LC-MS.
Results indicate that spectral quality is improved when using LC-IM-MS, compared
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to direct injection IM-MS, for which significant ion suppression effects were observed
in the electrospray ion source. The use of reversed-phase LC employing fast gradient
elution reduced sample preparation to a minimum, whilst maintaining the potential for
high throughput analysis.  Data mining allowed information on specific analytes to be
extracted from the complex metabonomic data set. LC-IM-MS based approaches may
have a useful role in metabonomic analyses by introducing an additional
discriminatory dimension of ion mobility (drift time). The combination of liquid
chromatography with with field asymmetric waveform ion mobility spectrometry
(FAIMS) and mass spectrometry, using electrospray ionisation (ESI), was used for
gas-phase analyte separation based on mass-to-charge (m/z) ratio and characteristic
compensation voltages (CV). The selectivity by FAIMS/MS was exploited for the
metabonomic analysis of rat urine using a cylindrical FAIMS device coupled to a
linear ion trap mass spectrometer to attain LC-FAIMS-MS urinary profiles.
Urine samples from a groups of young and old Wistar rats were analysed by gradient
reversed phase HPLC, following centrifugation. Aliquots of a pooled sample were
used to form a multi–replicate QC set to test and condition the IM-MS system.. Six
compensation voltages were selected to cover the range for metabolite detection and
the FAIMS selected fractions analysed by ion trap mass spectrometry. This study
further demonstrated that the combined LC-FAIMS-MS approach has the potential to
enhance selectivity and improve mass spectral quality for analytes of interest
compared to LC-MS alone. Statistical analysis of data from the LC-FAIMS-MS
analysis of rat urine samples using artificial neural networks, with rank ordering of
ions, allowed the young and old rats to be distinguished with an RMS of less than
0.162% Future investigation using negative ion mode data could be investigated and
154
may yield improved performance and show greater discrimination of the urinary
profiles. Tandem mass spectrometry and metabolite identification could also be
performed. Future studies could also look at the potential of IM-MS and FAIMS-MS
for the detection of novel and established biomarkers of disease states from urinary
profiles.
Chapter 4 demonstrates proof of principle for the use of IM-MS for reaction
monitoring applied to the direct, real-time analysis of the products formed when 7-
fluoro-6-hydroxy-2-methylindole is deprotonated by sodium hydroxide. The use of
orthogonal IM and MS analysis yields data comparable to mass spectrometry alone,
but with the addition of an ion mobility dimension. Ion mobility-mass spectrometry
can be employed as a rapid means to analyse a model chemical reaction mixture,
offering the potential for real-time reaction monitoring. The IM-MS approach has
been shown to have potential to enhance visualization of the data selectivity for
analytes compared with MS alone, as a direct result of the orthogonal mobility and
mass-to-charge separation.  Further work could be undertaken to investigate the
potential of on-line monitoring of genotoxic impurities within pharmaceutical
formulations employing DESI. These further studies will give an indication of the
potential to employ IM for on-line monitoring without the need for sample
preparation.
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Abstract
The potential of drift tube ion mobility (IM) spectrometry in combination with high
performance liquid chromatography (LC) and mass spectrometry (MS) for the
metabonomic analysis of rat urine is reported. The combined LC-IMMS approach
using quadrupole/time-of-flight mass spectrometry with electrospray ionisation, uses
gas-phase analyte characterisation based on both mass-to-charge (m/z) ratio and
relative gas-phase mobility (drift time) following LC separation. The technique
allowed the acquisition of nested data sets, with mass spectra acquired at regular
intervals (65 s) during each IMS separation (~13 ms) and several IMS spectra
acquired during the elution of a single LC peak, without increasing the overall
analysis time compared to LC-MS.   Preliminary results indicate that spectral quality
is improved when using LC-IMMS, compared to direct injection IMMS, for which
significant ion suppression effects were observed in the electrospray ion source. The
use of reversed-phase LC employing fast gradient elution reduced sample preparation
to a minimum, whilst maintaining the potential for high throughput analysis.  Data
mining allowed information on specific analytes to be extracted from the complex
metabonomic data set. LC-IMMS based approaches may have a useful role in
metabonomic analyses by introducing an additional discriminatory dimension of ion
mobility (drift time).
Keywords:
Ion mobility-mass spectrometry; reversed phase HPLC; metabonomics; urinary
metabolome.
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1. Introduction
A number of analytical methods have been employed to produce metabolic signatures
of biomaterials. The main techniques currently used in metabonomic studies are high
resolution nuclear magnetic resonance (NMR) spectroscopy [1-3], gas
chromatography-mass spectrometry (GC-MS) [4-6], liquid chromatography-mass
spectrometry (LC-MS) [4, 7-9], including ultra performance liquid chromatography
(UPLC) [10], and capillary electrophoresis-mass spectrometry (CE-MS) [11] (for a
recent review of analytical strategies in this area see [12]). All these techniques result
in complex multivariate data sets, which in turn require bioinformatic methods for
visualisation and interpretation. There are various advantages in employing NMR in
metabonomic/metabolomic studies because the technique is non-destructive and
applicable to the direct analysis of biofluid samples and intact biomaterials, with
minimal or no sample preparation, for example the direct analysis of tissue employing
magic angle spinning NMR [13]. NMR spectroscopy also has good potential for
structure determination.  However, there are limitations for NMR-based metabonomic
studies including issues around sensitivity (>1 nmol metabolite for 1H-NMR
detection) and the inability to detect some nuclei (e.g. O and S).  MS is inherently
more sensitive than NMR (though sensitivity is compound dependant) and also has
the potential for molecular identification using tandem MS fragmentation or accurate
mass determination.
Ion mobility (IM) spectrometry is a gas-phase electrophoretic technique which allows
ionized analytes to be characterised on the basis of their ion mobility (K), defined by
the reduced mass (µ), charge (e) and collision cross section (Ω) (i.e., size and shape)
of the ion (eqn 1) [14].
161
where N is the number density of the buffer gas, kB is the Boltzmann constant and T is
the temperature. The time (td) taken for an analyte ion to traverse a drift cell (of length
l), under the influence of a weak electric field (E) and in the presence of a buffer gas
is determined by the mobility of the ion, so mixtures of analyte ions may be separated
on the basis of their relative drift times.
td = l/K.E
The principles and applications of IM have been the subject of several recent reviews
[15-17].
The combination of ion mobility spectrometry with mass spectrometry (IM-MS), as
shown in Fig. 1, allows ions generated in the ion source to be separated initially by
their mobility in the low pressure drift cell and then by mass-to-charge ratio in the fast
scanning time-of-flight (TOF) mass analyser. The coupling of these complementary
techniques therefore provides a multidimensional separation of gas-phase ions.
IM is a separation technique that has not until recently been used in bioanalytical
applications, but preliminary studies have shown that using IM can aid the analysis of
small molecules in complex systems [18] and IM-MS has proved to be a valuable tool
for proteomic research [19-21].  The application of IM-MS using an atmospheric
pressure drift tube to the analysis of metabolic mixtures has recently been reported for
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extracts of bacterial cell cultures (E. coli) infused directly into the ESI ion source of
the spectrometer [22]. IM-MS analysis of the human glycourinome using pre-
fractionated urine has also been reported [23]. These studies suggest that LC
hyphenated with IM-MS, may have potential for enhancing metabonomic studies
without the requirement for additional sample clean-up.  In this communication, we
describe a preliminary evaluation of the potential of LC-IM-MS using a low pressure
IM drift cell for the analysis of the urinary metabolome without prior extraction. Fast
gradient reversed-phase liquid chromatography was used for the rapid elution of
endogonous metabolites, prior to electrophoretic separation and m/z measurement by
IM-MS.
2. Experimental
2.1. Chemicals
Methanol (HPLC grade), acetonitrile (HPLC gradient grade) and formic acid (99.5%
Puriss grade) were purchased from Thermo Fisher Scientific (Loughborough, UK).
Distilled and deionised water was obtained in-house using a Triple red water
purification system (Triple red, Long Crendon, UK).
2.2 IM-MS and LC-IM-MS method
All experiments were carried out employing a prototype IM-Q-TOF-MS (Waters
Corporation, Manchester), which is shown schematically in Fig. 1 and has been
described in detail elsewhere [14]. Ions from the ESI source were directed into the
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trap region at the head of the ion mobility drift cell, which was operated in the
pressure region of 1.0 to 3.0 Torr N2.  Ions were gated into the drift cell using a gate
electrode pulse (3.50 V, 200 µs pulse width and 15ms pulse period). The IM drift tube
consisted of a multi-plate ion guide (15.2 cm in length) to which a voltage gradient
(14.24 V/cm and a supplement RF voltage 3.8 V) were applied to facilitate separation
of ion species by relative mobility.  Ions passing through the drift region were then
directed into the reflectron TOF mass analyses.  Ion mobility spectra were acquired by
collecting data from 200 TOF pushes (65 µs per bin) and plotting drift time (scan)
against mass-to-charge ratio (m/z).  IM-MS data were typically accumulated for 5 s,
with a 2 s interscan delay. Initial studies using direct introduction of urine samples
into the IMS-Q-TOF-MS spectrometer without chromatographic separation were
preformed by infusing the aliquots of the prepared urine into the ESI ion source at 10
l/min using the integrated syringe pump.
Liquid chromatography was performed on a Waters Alliance 2790 chromatograph
(Waters Corporation, Manchester, UK) fitted with a Symmetry® (Waters
Corporation, Manchester, UK) C18 column (2.1 x 50 mm, 5 µm).  The LC system
was coupled to the ESI ion source of the IM-Q-TOF-MS spectrometer.  Urine samples
(50 µl injected) were eluted with the following gradient: 100% A (0-2 min), increased
to 100% B (2-5 min) and then to 100% A (5-8 min), where A = 0.1% aqueous formic
acid and B = 0.1% formic acid in acetonitrile. The mobile phase flow rate was set to
0.200 ml/min. Electrospray ionization conditions for the MS, with the ion source
operated in positive ion mode were: capillary voltage, 3.5 kV; cone voltage 60 V;
source temperature 120°C; desolvation gas, N2 gas flow 250 l/hr; desolvation gas
temperature, 180°C.   Masslynx version 4.1 (Waters Corporation, Manchester, UK)
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was used to control the LC and IM-MS instrument and for data acquisition.  Data
mining was carried out using DriftScope version 1.0 (Waters Corporation,
Manchester, UK).
2.3 Urine sample preparation
Urine samples from male Wistar-derived rats were provided by AstraZeneca
(Alderley Park, Macclesfield, UK).  Aliquots of a pooled urine (n=4) were used for
IM-MS and LC-IM-MS studies. The urine was centrifuged at 13,000 rpm for 5
minutes to remove particulates and then frozen to -80°C prior to analysis.
3. Results and discussion
Initial experiments were carried out by directly infusing aliquots of urine into the ESI-
IM-Q-TOF-MS spectrometer as described in the experimental section. However, the
salt component of the urine caused significant ion suppression in the electrospray ion
source (data not shown) and hence liquid chromatography was employed to reduce
these suppression effects.  The urinary metabolic profile is composed mainly of
relatively polar/ionic substances, which must be retained on the LC column whilst the
salts elute prior to mass spectrometry analysis. In order to obtain the best possible
retention of these polar metabolites, we therefore used a gradient separation where the
initial segment (0-2 min) was entirely aqueous formic acid, followed by a rapid
increase (over 5min) to 100% acetonitrile. The effectiveness of the LC column for
improving spectral quality is shown in the LC-ESI-IM-MS data for a pooled urine
sample obtained from the Wistar-derived rats, shown in Fig. 2.  The peaks in the LC
chromatogram correspond to the IM spectra accumulated during the LC run (Fig.
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2(a)). The salt component was eluted in less than 1 minute (Fig. 2(a)) showing ion
suppression effects and an increased noise in the mass spectrum (Fig. 2(b)), leaving
the metabolites and other components of the urine to be eluted in the region 3-8
minutes, free from salt interferences (Fig. 2(c)).
The effect of introducing an IM separation in tandem with LC and MS analysis of
urinary metabolites is shown in Fig. 3. In this experiment, data were acquired as
nested data sets, with mass spectra (65 s/scan) and IM spectra (~13 ms) scanned
repetitively throughout the LC run. Spectra were accumulated to yield 200 mass
spectra and one ion mobility spectrum every 7 s. The ion mobility drift time is plotted
as ‘bins’, where each bin corresponds to an acquired mass spectrum. The nested data
acquisition of IM and MS data results in an analysis incorporating a gas-phase
electrophoretic separation of the ESI generated ions on the basis of charge state and
collision cross section (i.e. size and shape), between the reversed-phase
chromatography and mass analysis, all within the timescale of the LC-MS run (Fig.
3(a)). IM has a relatively poor resolving power, with a typical full width at half height
(FWHH) resolution of 10, corresponding to ~500 theoretical plates in total. However,
peak capacity is increased in LC-IM-MS, because the IM separation is orthogonal to
that of LC retention and mass-to-charge ratio.
The mass spectrum shown in Fig. 3(b) was generated by summing all 200 mass
spectra in each IM scan and is therefore equivalent to the mass spectrum for LC-MS
analysis without IM separation. Fig. 3(c) shows the IM spectrum summed over all m/z
values and corresponds to LC-IM analysis without mass separation. The enhanced
separation afforded by the combined IM-MS analysis is shown in the 2-D plot of ion
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drift time (bins) vs m/z, which is presented in Fig. 3(b) for data averaged over the
whole LC run (0-7 min). The bands of colour reflect the intensity of the ions with red
representing the highest intensity and blue/white the lowest intensity.
Analysing these multidimensional data sets presents a challenge for multivariate
statistical techniques commonly used in comparative metabonomics, since
conventional statistical theory requires at least twice as many sample replicates as the
number of dimensions in the data. Advanced bioinformatic techniques are required,
such as artificial neural networks, which are capable of handling complex,
multidimensional and non-linear data sets [24]. An alternative approach is to reduce
the complexity of the data by selecting retention time and drift time windows for
analysis, or by other pre-treatment strategies [25].
A retention time region (3.6 – 3.9 min) from the LC run was selected because of the
many metabolites eluting in this time window and Figure 4 shows the IM-MS data
associated with this region. There is a significant reduction in background noise
(indicated by an increase in blue/white shading) and an overall simplification of the
drift time vs m/z analytical space. The IM and MS spectra shown in Fig. 4(b) and 4(c)
were obtained by averaging the drift time and m/z data shown in Fig. 4(a). The
resulting spectra (Fig. 4(b) and 4(c)) therefore correspond to those expected for LC-
IM (Fig. 4(b)) and LC-MS (Fig. 4(c)) separations respectively.
It is possible to enhance selectivity for target analytes by utilising the orthogonal
separation of the LC, IM and MS dimensions. This is illustrated in Fig. 5 for the m/z
162.1 ion, assigned to the endogenous metabolite carnitine (C7H15NO3) [21].  The
extracted ion chromatogram for this ion is shown in Fig. 5(a). The ion intensity
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reaches a maximum at a retention time of 3.8 min and the selected ion mobility
response for the m/z 162.1 ion in the ion mobility spectra acquired in the retention
time window 3.6 – 3.9 min is shown in Fig. 5(b).  The sharp peak observed in the drift
time region corresponding to bins 20-25 contrasts with broad total ion mobility
response observed in the same retention time window when all 200 bins were
averaged, seen in Fig. 4(b). The mass spectrum obtained by averaging the spectra in
the region 20-25 bins (Fig. 5(c)) has m/z 162 as the base peak. Comparing this
spectrum with that shown in Fig. 4(c), which is equivalent to the LC-MS analysis
without mobility selection, demonstrates the effectiveness of the orthogonal LC, IM
and MS analysis in simplifying and improving spectral quality. Confidence in the
assignment of targeted or unknown species is increased by the presence of an ion of
the correct m/z at the expected IM drift time and the LC retention time associated with
a metabolite.
4. Conclusions
This study demonstrates that nested LC-IM-MS data may be acquired on directly
injected urine samples within the timescale of an LC-MS experiment. The combined
LC-IM-MS approach has the potential to enhance the metabonomic coverage by the
introduction of a gas-phase electrophoretic separation that is orthogonal to the
reversed-phase LC and mass-to-charge MS separations. Data mining for the detection
of a targeted analyte is also demonstrated yielding improved spectral quality and
confidence in assignment.
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Legends to Figures
Figure 1. Schematic diagram of the prototype IM-Q-TOF-MS spectrometer.
Figure 2. (a) LC chromatogram showing accumulated IM spectra derived from the
LC-IM-MS analysis of urine obtained from male Wistar-derived rats, (b) mass
spectrum corresponding to retention time window 1.0 – 1.3 min, (c) mass spectrum
corresponding to retention window 5.5 – 6.0 min.
Figure 3. LC-IM-MS analysis of urine obtained from male Wistar-derived rats, (a) LC
chromatogram, (b) the  mass spectrum generated by summing all 200 mass spectra in
each IMS scan during the LC run, (c) total ion mobility spectrum summed over all
m/z values, (d) 2D plot of drift time (bins) versus m/z plot for the full data set.
Figure 4. (a) Drift time (bins) versus m/z plot of selected retention window 3.6-3.9
minutes derived from the LC-IM-MS analysis of rat urine, (b) total ion mobility
spectrum corresponding to retention time window 3.6-3.9 minutes, (c) mass spectrum
corresponding to total ion mobility spectrum of retention time window 3.6-3.9
minutes.
Figure 5.  (a) Extracted ion chromatogram (XIC) for m/z 162.1 obtained from the LC-
IM-MS analysis of male Wistar-derived rat urine, (b) selected ion mobility spectrum
of m/z 162.1, corresponding to the selected retention time window 3.6-3.9 min, (c)
mass spectrum corresponding to selected ion mobility spectrum for m/z 162.1 (IM
bins 20-25 combined).
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Abstract
The direct analysis of pharmaceutical formulations and active ingredients from non-
bonded reversed-phase thin layer chromatography (RP-TLC) plates by desorption
electrospray ionisation (DESI) combined with ion mobility-mass spectrometry (IM-
MS) is reported.  The analysis of formulations containing analgesic (paracetamol),
decongestant (ephedrine), opiate (codeine) and stimulant (caffeine) active
pharmaceutical ingredients is described, with and without chromatographic
development to separate the active ingredients from the excipient formulation.
Selectivity was enhanced by combining ion mobility and mass spectrometry to
characterise the desorbed gas-phase analyte ions on the basis of mass-to-charge (m/z)
ratio and gas-phase ion mobility (drift time).  Varying the solvent composition of the
DESI spray using a step gradient was employed to optimise the desorption of active
pharmaceutical ingredients from the RP-TLC plates. The combined RP-
TLC/DESI/IM-MS approach has potential as a rapid and selective technique for
pharmaceutical analysis by orthogonal gas-phase electrophoretic and mass-to-charge
separation.
Keywords:
Ion mobility-mass spectrometry; reversed-phase thin layer chromatography; DESI;
Gradient DESI.
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Desorption electrospray ionisation provides a means by which analytes can be
sampled from the surface under ambient conditions, ionised and detected.1
Introduced in 2004 by Takats et al.2 DESI lends itself to the analysis of molecules that
are amenable to conventional electrospray ionisation (ESI).  DESI has been reported
for the analysis of both polar and non-polar analytes, including proteins and peptides,3
pharmaceuticals,4 metabolites,5 lipids,6 and biological tissues.7 The desorption of
analytes  directly from  surfaces by DESI is achieved by directing electrosprayed
droplets at the surface  under interrogation, producing ESI type spectra within a few
seconds with the appropriate choice of  desorbing solvent.  Several ionisation
mechanisms have been proposed including the well established chemical sputtering or
droplet pick-up mechanism,8 in which analytes on the surface are picked up by the
impacting droplets, followed by gas phase ion formation via electrospray
mechanisms.  Alternative mechanisms involve charge transfer between a gas phase
ion and analytes on the surface and gas-phase ion/molecule reactions.9
Thin layer chromatography (TLC) remains a widely used technique for the separation
of mixtures for both qualitative and quantitative analysis, but has limitations with
respect to the identification of the separated analytes. To overcome this limitation
there have been many attempts to couple TLC with MS using ionization techniques
such as fast atom bombardment (FAB) and matrix assisted laser desorption ionisation
(MALDI).10  In this context, DESI as a sample introduction method for MS seems
ideally suited to combination with TLC and its use has been described with normal
phase silica gel11 and cellulose12 plates for the study of medicinal herbs13, dyes,13-14
alkaloids,15 proteins and peptides16 and pharmaceutical formulations.17  The
application of DESI to the analysis of analytes from hydrophobic, reversed-phase
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TLC plates with bonded silica phases has been investigated for the analysis of dyes18-
20and caffeine extracted from beverages.21 More recently, Wiseman et al reported the
use of pressurised planar electrochromatography using reversed-phase C18 plates for
the study of steroids.22 DESI/MS has also been employed for the chemical imaging of
dyes separated on TLC plates.11 The desorption of analytes from non-bonded,
reversed-phase TLC plates by DESI has not been previously reported and presents
additional challenges because the plates cannot be pre-cleaned to reduce background
contamination prior to analyte deposition and there may be interference from
stationary phase molecules being desorbed together with the analyte.
Ion mobility spectrometry is a gas-phase electrophoretic technique which allows
ionized analytes to be characterised on the basis of their ion mobility (K), defined by
the reduced mass (µ), charge (e) and collision cross section (Ω) (i.e., size and shape)
of the ion (Eqn 1)23
where N is the number density of the buffer gas, kB is the Boltzmann constant and T is
the temperature. The time (td) taken for an analyte ion to traverse a drift cell (of length
l), under the influence of a weak electric field (E) and in the presence of a buffer gas
is determined by the mobility of the ion (Eqn 2), so mixtures of analyte ions may be
separated on the basis of their relative drift times which are typically on the
millisecond timescale.
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td = l/K.E
The combination of ion mobility spectrometry with mass spectrometry (IM-MS),
allows gas-phase ions generated in the DESI ion source to be separated first by their
mobility in a drift cell and then by mass-to-charge ratio in the mass analyser,
providing a multidimensional separation with increased selectivity for the analytes of
interest.
DESI/IM-MS has been reported for the direct analysis of active ingredients in
pharmaceutical formulations, demonstrating the benefits offered by the additional
dimension of IM.24  Further studies described the use of DESI/IM-MS for the analysis
of peptides25 and conformational studies of folded and denatured states of proteins.26
In more recent investigations, DESI was coupled with a travelling-wave based ion
mobility-mass spectrometer for the analysis of drugs.27
In this paper, we describe the use of DESI/IM-MS for the detection of active
pharmaceutical ingredients deposited and developed on non-bonded reversed-phase
TLC plates. A step gradient of the desorption solvent was used to optimise the DESI
solvent composition.
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Experimental
Materials
Acetonitrile (HPLC gradient grade) and water (HPLC grade) were purchased from
Thermo Fisher Scientific (Loughborough, UK).  Mass spectrometry grade (puriss, p.a)
formic acid was purchased from Sigma-Aldrich (Gillingham, UK).   Generic Co-
codamol tablets containing 500 mg paracetamol and 8 mg codeine and a generic cold
and flu tablets containing 250 mg paracetamol, 25 mg caffeine and 8mg ephedrine
were purchased over the counter.
Sample preparation
Tablets were crushed and extracted in water (2 mL) and filtered (Whatman filter
paper, qualitative).  The extracted solution was manually spotted onto the reversed-
phase hydrocarbon impregnated silica gel TLC plates (Analtech Uniplates, Newark,
USA; 10 x 20 cm, 250 microns) in 1µL aliquots up to 6µL in total volume.  The plates
were developed in a saturated chamber with 50/50 (v/v) methanol-water.
DESI/IM-MS analysis
The DESI/IM-MS ion source region is shown in Figure 1. All experiments were
carried out employing a prototype IM-quadrupole time-of-flight mass spectrometer
(Waters Corporation, Manchester) which has been described in detail elsewhere.24
The atmospheric pressure ionisation (API) region of a Z-spray electrospray ionisation
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source was modified for DESI by attaching a section of TLC plate to a manipulator,
allowing horizontal, vertical and rotational manipulation of the plate, which was
located in the atmospheric pressure ionisation region of the mass spectrometer at an
approximate 45° angle relative to the spray tip and cone.  A Waters Alliance 2790
chromatograph (Waters Corporation, Manchester, UK) was coupled to the modified
DESI ion source of the IM-Q-ToFMS spectrometer to provide the DESI solvent flow.
A split was employed to reduce the solvent flow rate to the DESI probe (typically 25
µL/min) from the higher flow through the LC system (200 µL/min).  The area of
sample desorbed when the DESI probe and sample position were optimised was
approximately 1 mm in diameter.  Variable solvent composition experiments were
carried out in which the TLC plate was analysed using three different solution
compositions using the following step gradient: 10% A (0-1.5 min), increased to 50%
A (1.5-3.0 min) and then to 90% A (3.0-4.5 min), where A = 0.1% aqueous formic
acid and B = 0.1% formic acid in acetonitrile.  At each gradient step change the DESI
source was moved in the vertical plane ensuring that an area of the TLC plate under
interrogation had not previously been exposed or desorbed.  Solvent and gas flow
directed at the ionisation surface also creates a washing effect.  The vertical
movement of the sample stage ensured that that the solvent plume from the previous
row was not interrogated.
The IM-Q-ToFMS was operated in positive ion mode with the ESI capillary voltage
set to 3.5 kV; cone voltage 40 V; source temperature 120 °C; desolvation gas, N2 gas
flow 250 L/hr; desolvation gas temperature, 180 °C. Ions from the DESI source were
directed into the trap region at the head of the ion mobility drift cell and periodically
gated into the drift cell, which was operated in the pressure region of 1.0 to 3.0 Torr
N2, using a gate electrode pulse (3.50 V, 200 µs pulse width and 15ms pulse period).
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The IM drift tube consisted of a multi-plate ion guide (15.2 cm in length) to which a
voltage gradient (14.24 V/cm and a supplement RF voltage 3.8 V) were applied.  Ions
passing through the drift region were then directed through the quadrupole and
collision cell into the reflectron TOF mass analyser. The quadrupole was operated in
wide band pass mode (m/z 50-1000) and the collision cell without any collision gas.
Ion mobility spectra were acquired by collecting data from 200 TOF pushes (45 µs
per bin) and plotting drift time (scan number) against mass-to-charge ratio (m/z).  IM-
MS data were typically accumulated for 5 s, with a 2 s interscan delay. Acquired data
were presented as a plot of time against ion intensity; total ion mobility response or
selected ion mobility responses.  Masslynx version 4.1 (Waters Corporation,
Manchester, UK) was used to control the IM-MS instrument and for data acquisition
and processing.
 Results and discussion
Pharmaceutical formulations containing paracetamol, caffeine, codeine and ephedrine
were analysed by DESI/IM-MS directly from the surface of non-bonded RP-TLC
plates, generating mass-to-charge and mobility data for the desorbed ions.
Optimisation of  the positioning of the sample relative to the atmospheric pressure
ionisation region of the mass spectrometer, including the spray tip and cone (Figure 1)
was found to be a critical parameter influencing analyte signal intensity.  The
optimum position was determined by manipulation of the sample in the horizontal,
vertical and rotational planes with the maximum analyte response observed at an
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angle of 45° relative to the spray tip and cone.  A further parameter found to effect
analyte responses significantly was the DESI solvent flow rate.  An increase in flow
correlated with an increase in analyte signal response and the amount of analyte
desorbed from the RP-TLC plate surface.  The signal intensity for the active
ingredients paracetamol and codeine showed a nine-fold increase when the DESI
solvent flow rate was increased from 2 µL/min to 5 µL/min.  A further increase in ion
intensity was observed up to a flow rate of 50 µL/min, but only a small increase in
signal response was observed at flow rate above an optimised flow of 25 µL/min. The
TLC plates showed a clear “wetting effect”, with a solvent layer forming on the
surface under interrogation by the incident electrospray, which facilitates the
extraction of analytes from the surface into the thin liquid layer.
High noise levels were observed in the resulting DESI mass spectra, presumably as a
result of interferences present on the plate or ablation of the hydrocarbon stationary
phase, which was a non-bonded phase and could not, therefore, be washed prior to
sample loading. IM-MS data were acquired by repetitive scanning of nested data sets,
with mass spectra (45 s/scan) and IM spectra (~13 ms) scanned repetitively
throughout the LC run. Spectra were accumulated to yield 200 mass spectra and one
ion mobility spectrum every 7 s. The ion mobility drift time is plotted as ‘bins’, where
each bin corresponds to an acquired mass spectrum. The nested data acquisition of IM
and MS data results in an analysis incorporating a gas-phase electrophoretic
separation of the ESI generated ions on the basis of charge state and collision cross
section (i.e. size and shape), between the  mass analysis, all within the timescale of
the MS run.
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Total ion and selected ion mobility responses for the active pharmaceutical
ingredients extracted from a generic cold and flu tablet, including ephedrine,
paracetamol and caffeine, deposited on the TLC plate without solvent development,
are displayed in Figure 2.  Selected ion responses for protonated ephedrine (m/z 168;
Figure 2(a)), paracetamol (m/z 152; Figure 2(b)), and caffeine (m/z 195; Figure 2(c))
showed drift times of 0.90 ms (bin 20), 0.95 ms (bin 21) and 1.04 ms (bin 23)
respectively.   The selected ion responses are much cleaner and sharper then the total
ion mobility spectrum with peak widths at half height of  5 bins (ephedrine), 3 bins
(paracetamol) and 4 bins (caffeine) compared to 11 bins for the total ion mobility
spectrum. The corresponding mass spectra are also shown in Figure 3. The mass
spectrum obtained by combining all 200 bins (Figure 3(d)) corresponds to the mass
spectrum expected in the absence of IM separation and contain a large number of
desorbed ions across the whole mass range.  In contrast, when the mass spectra
obtained by combining bins at the drift times (bins 15-24, 18-23 and 21-25; Figure 2)
of the active ingredient peaks (Figures 3(a), (b) and (c)) are compared to the mass
spectrum from the combined total ion mobility response, the enhanced selectivity for
the actives is observed. The resulting mass spectra show fewer ions and, in the case of
paracetamol (m/z 152) and caffeine (m/z 195), the [M+H]+ ion is the base peak.
Paracetamol was the most abundant component in the cold and flu tablet (250 mg per
tablet); however, caffeine (25 mg per tablet) showed the highest IM-MS response, as
a result of higher DESI ionisation efficiency from the TLC plate.  On the basis of the
amount of active ingredient spotted on the plate the limit of detection (LOD) (3:1
signal-to-noise) was estimated to be  16 µg/cm2, 34 µg/cm2 and  239 µg/cm2 for
caffeine, ephedrine and paracetamol respectively.
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Total ion and selected ion mobility responses obtained from the DESI/IM-MS
analysis of paracetamol and codeine extracted from a generic Co-codamol tablet,
following separation by TLC, are displayed in Figure 3, together with an image of the
developed reversed-phase plate.  LOD were again estimated on the basis of the
amount spotted for both the active ingredients within the co-codamol tablet.
Paracetamol was found to have a LOD of 225 µg/cm2 and codeine 9 µg/cm2.  This
lower limit of detection for paracetamol following chromatographic separation may
be due to the distribution of paracetamol in the developed and undeveloped spots or
reduced ion suppression due to separation of the excipient components from the active
pharmaceutical ingredient.  The drift time for paracetamol (Figure 4(a)) was 0.90 ms
(bin 20) showing good IM reproducibility for the RP-TLC/DESI/IM-MS analysis of
paracetamol (Figure 2(b)). The sharp peak observed in the m/z 152 selected ion
response for paracetamol (Figure 4(a)) contrasts with the broad total ion mobility
response when all 200 bins were averaged, shown in Figure 4(b). The mass spectrum
obtained by averaging the spectra in the range bin 19-23 (Figure 4(c)) has m/z 152 as
the base peak. Comparing this spectrum with that shown in Figure 4(d), which is
equivalent to the DESI-MS analysis without mobility selection, demonstrates the
effectiveness of the orthogonal IM and MS analysis in simplifying and improving
spectral quality.  Analysis of the developed codeine spot also shows an increased
selectivity for the active ingredient.  Figure 5 displays the total ion response and the
selected ion response for m/z 300, assigned to protonated codeine with a drift time of
2.3 ms.  The corresponding mass spectra are shown in Figure 5(c) and 5(d).
Comparing the mass spectrum corresponding to the codeine selected ion response
with the total ion response shows that the additional separation of ion mobility
improves selectivity for codeine.  It should be noted that the paracetamol (Figure
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4(a)), and codeine (Figure 5(a)), selected ion mobility responses were fully resolved
by the ion mobility separation.
Method development experiments, although essential are often time consuming and
relatively expensive.  In this work, the solvent composition of the DESI spray was
varied by employing a step gradient to determine the optimum solvent for desorption.
Extracted Co-codamol was spotted onto the TLC plate, which was analysed
sequentially using three different solvent compositions (90:10, 50:50, 10:90,
acetonitrile:water with 0.1% formic acid).  Figure 6 shows signal response (m/z 300)
versus % organic solvent.  Signal responses were determined from the mass spectra
corresponding to the selected ion mobility response for codeine combining bins across
the peak at half height. It can be seen that codeine displayed increasing signal
response as the organic component of the spray was reduced, which correlates with
the high aqueous solubility of codeine (1 g in 0.7 mL at 25 °C).  A greater % of water
would facilitate extraction of codeine from the surface of the TLC plate into the
wetted surface layer.
Chemical imaging of the developed codeine spot was carried out by rastering across
the spot to obtain a 1-D image.  The DESI sampling stage was moved in increments
of 0.5 mm in the vertical plane to move the DESI plume across the spot and IM-MS
spectrum were acquired and accumulated at each point.  Ion mobility spectra,
consisting of 200 mass spectra (bins), were averaged and the selected ion mobility
response for m/z 300 extracted from the data.  The image obtained for the mass
spectral ion intensity of m/z 300 at the drift time for codeine, is displayed in Figure 7.
The codeine response for the TLC spot shows a maximum intensity at 16 mm
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corresponding to the Rf of codeine (Rf = 0.16).  The 1-D image allows peak areas to be
calculated for quantitative analysis by DESI.
 Conclusion
This study has demonstrated that active pharmaceutical ingredients can be desorbed
by DESI directly from non-bonded RP-TLC plates, with or without separation from
the excipient components. Variation of the solvent composition of the DESI spray
using a step gradient allows the optimisation of the method for analytes can be
achieved with reduced development times.  The combined RP-TLC/DESI/IM-MS
approach has been shown to have potential to enhance selectivity for analytes
compared to DESI/MS alone.  Improved mass spectral quality was observed in all
cases when IM separation was used in conjunction with mass spectrometry as a result
of the orthogonal mobility and mass-to-charge separation.
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Figure 1.  (a) Schematic diagram of DESI source and mass spectrometer interface, (b)
photograph of the ion source region.
Figure 2.  Ion mobility spectrum and selected ion mobility responses for the
DESI/IM-MS analysis of a generic cold and flu tablet obtained from a RP-TLC plate
without development, using DESI with a solvent composition of 50:50 (v/v)
acetonitrile:water with 0.1% formic acid at a flow rate of 25 µl/min. (a) m/z 168
(ephedrine), (b) m/z 152 (paracetamol), (c) m/z 195 (caffeine), and (d) total ion
mobility spectrum.
Figure 3. Mass spectra corresponding to selected ion mobility responses for the
DESI/IM-MS analysis of a generic cold and flu tablet obtained from a RP-TLC plate
without development (a) bins 15-24 (ephedrine), (b) bins 18-23 (paracetamol), (c)
bins 21-25 (caffeine), and, (d) mass spectrum obtained by combining all 200 bins
acquired during the ion mobility separation.
Figure 4.  Ion mobility spectrum and selected ion mobility response for the DESI/IM-
MS analysis of a generic Co-codamol tablet obtained from a RP-TLC plate  following
chromatographic development, using DESI with a solvent composition of 50:50 (v/v)
acetonitrile:water with 0.1% formic acid at a flow rate of 20 µl/min. (a) selected ion
response for m/z 152 (paracetamol), (b) total ion mobility spectrum, (c) mass
spectrum corresponding to the selected ion response for m/z 152 (bins 19-23), (d)
mass spectrum obtained by combining all 200 bins acquired during the ion mobility
separation.
193
Figure 5.  Ion mobility spectrum and selected ion mobility response for the DESI/IM-
MS analysis of a generic Co-codamol tablet (conditions as Figure 4), (a) selected ion
response for m/z 300 (codeine), (b) total ion mobility spectrum, (c) mass spectrum
corresponding to the selected ion response for m/z 300 (bins 48-59), (d) mass spectra
corresponding to the total ion response.
Figure 6. RP-TLC/DESI/IM-MS analysis of an extracted Co-codamol tablet
employing a step gradient for the DESI analysis (90:10, 50:50, 10:90,
acetonitrile:water with 0.1% formic acid): signal response versus % organic solvent
for m/z 300 ion (codeine).
Figure 7.  RP-TLC/DESI/IM-MS selected ion response for scanned 1-D image,
showing signal distribution along a lane of the codeine TLC spot (m/z 300 and bin
53).  Dashed line represents scan direction.
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Real-time reaction monitoring using ion mobility-mass spectrometry
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Summary
The potential of ion mobility (IM) spectrometry in combination with mass
spectrometry (MS) for real-time reaction monitoring is reported.  The combined IM-
MS approach using electrospray ionization affords gas-phase analyte characterization
based on both mass-to-charge (m/z) ratio and gas-phase ion mobility (drift time).  The
use of IM-MS analysis is demonstrated for the monitoring of the reaction products
formed when 7-fluoro-6-hydroxy-2-methylindole is deprotonated by aqueous sodium
hydroxide.  Real-time reaction monitoring was carried out over a period of several
hours, with the reaction mixture sampled and analysed at intervals of several minutes.
Results indicate that spectral quality is improved when employing IM-MS, compared
to mass spectrometry alone, as the complexity of the reaction mixture increases with
time.  The combined IM-MS approach has potential as a rapid and selective technique
to aid pharmaceutical process control and for the elucidation of reaction mechanism.
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Introduction
Process understanding and validation is an essential requirement for process control,
to assure quality and purity in the manufacture of chemicals and pharmaceuticals. The
Food and Drug Administration (FDA) has recognised that process knowledge is key
to quality and, through better understanding, to building a cause and effect model that
improves process control.1 The pharmaceutical industry also requires quick, efficient,
sensitive and high throughput methods for both quality control and quality assurance
of drug products. Real-time reaction monitoring can provide detailed information
about the course of a reaction and in turn aid process understanding. Current
techniques employed for real-time reaction monitoring include, liquid
chromatography (LC),2 mass spectrometry,3 infrared spectroscopy,4 nuclear magnetic
resonance5 and near infrared spectrometry6 However, there is a need to develop new
approaches for real-time reaction monitoring that provide enhanced quantitative and
structural information on reaction intermediates and products.
Ion mobility spectrometry (IM) is a gas phase electrophoretic technique which allows
ionised analytes to be characterised on the basis of their ion mobility (K) in the
presence of a buffer gas and under the influence of a weak electric field. K is defined
by the reduced mass (µ), charge (e), and collision cross section (Ω), which is
determined by the size and shape of the ion, according to Eq. (1)7
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Where N is the number density of the buffer gas, kB is the Boltzmann constant and T
is the temperature.  The drift time (td) of an ion is the time taken to transverse a drift
cell (of length l), under the influence of the electric field (E) and in the presence of the
buffer gas, and is determined by the mobility of the ion.  Mixtures of analyte ions
may, therefore, be separated on the basis of their relative drift times which are
typically in the millisecond timescale Eq. (2)
td = l/K.E Eq. 2
The combination of ion mobility spectrometry with mass spectrometry (IM-MS)
allows gas-phase ions generated in an electrospray ion source to be separated first by
their ion mobility in a drift cell and then by mass-to-charge ratio in the mass analyser.
The technique also lends itself to the acquisition of nested data sets, in which MS
spectra are acquired at regular intervals (45-60 µs) during each IM separation (~15
ms), thereby reducing analysis times whilst having the potential to improve selectivity
and data quality compared to MS analysis alone.8
IM has evolved into a technique for sensitive detection of many trace compounds and
a wide range of chemical species such as chemical warfare agents,9 biomolecules,10
drugs of abuse11 and inorganic substances.12 IM has also been reported for the online
monitoring of monomer concentrations in (semi-) batch emulsion polymerisation
reactors,13 the monitoring of yeast fermentation,14 part per billion level process
monitoring of ammonia in process streams15 thus indicating the potential of IM as a
rapid and precise measurement device for the monitoring of processes. More recently
IM has been reported in pharmaceutical applications ranging from cleaning
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verification of manufacturing equipment,16 direct formulation analysis17-19 and
protection of pharmaceutical workers health and safety.20 These studies suggest that
IM combined with MS, may have potential for enhancing pharmaceutical process
understanding and process control.
In this communication, we demonstrate proof of principle for the use of IM-MS for
reaction monitoring applied to the direct, real-time analysis of the products formed
when 7-fluoro-6-hydroxy-2-methylindole is deprotonated by sodium hydroxide. The
use of orthogonal IM and MS analysis yields data comparable to mass spectrometry
alone, but with the addition of an ion mobility dimension.
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Experimental
Chemicals.
Acetonitrile (HPLC gradient grade) and water (HPLC grade) were purchased from
Thermo Fisher Scientific (Loughborough, UK) Mass spectrometry grade (puriss, p.a)
formic acid and sodium hydroxide (ACS reagent, ≥ 97.0%) pellets were purchased
from Sigma-Aldrich (Gillingham, UK). 7-fluoro-6-hydroxy-2-methylindole was
provided by AstraZeneca (Macclesfield, UK).
Sample preparation and real time monitoring.
Stock solutions of 7-fluoro-6-hydroxy-2-methylindole were prepared at
concentrations of 0.1, 1, 3, 5, 10, 15, 20 and 50 µg ml-1 in 49.5/49.5/1 (v/v/v)
acetonitrile/water/formic acid for calibration procedures.
7-fluoro-6-hydroxy-2-methylindole (125 µg ml-1) was prepared in acetonitrile and
stirred for 10 minutes on ice. Aqueous sodium hydroxide (40 m moles) was prepared
in deionized water and added to the indole reaction vessel over a two minute period to
initiate the deprotonation reaction. The reaction vessel was maintained at a
temperature between -5 and 0 °C for the first six hours of the reaction, after which the
reaction vessel was left overnight to warm to room temperature. Aliquots (20 µl) of
the reaction mixture were removed from the reaction vessel and diluted to a
concentration within the linear dynamic range of the analysis in 49.5/49.5/1 (v/v/v)
acetonitrile/water/formic acid to quench the reaction for IM-MS analysis and infused
into the ESI source at 5 µl min-1. For real-time reaction monitoring, spectra were
recorded at regular intervals during the deprotonation of the indole. Thus, a time zero
spectrum was acquired before the addition of the sodium hydroxide and further
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spectra were acquired at  60, 80, 160, 220 minutes and 24 hr and 7 days after addition
of the sodium hydroxide.
Instrumentation.
Direct infusion IM–MS experiments were performed on a Synapt HDMS
spectrometer (Waters Corporation, Manchester, UK), operated in positive ion mode
with the ESI capillary voltage set to 3 kV and the cone voltage to 27 V. The nitrogen
desolvation and cone gas flow rates were set to 500 and 30 L h−1 respectively, with a
source temperature of 120 °C and desolvation gas temperature set to 300 °C. The ion
mobility region contains three (trap, IM, and transfer) travelling wave stacked ion
guides (TWIGS). The trap ion guide was used to accumulate ions and periodically
then release an ion packet into the IM ion guide for mobility separation. A full
description of the mode of operation of stacked ring ion guides with travelling waves
is given elsewhere.21 The travelling wave velocity was set to 300 ms−1 with a pulse
height of 12 V in all acquisitions. Ions were injected into the IM TWIG from the trap
TWIG for 200 μs in every ion mobility separation. Each ion mobility spectrum
consists of 200 sequential ToF mass spectra (acquisition time typically less than
15 ms). The quadrupole was operated in wide band pass mode (m/z 50-1000) and the
collision cell contained no collision gas. IM–MS data were obtained by combining the
ion mobility spectra acquired in a 120 s infusion. Acquired data were presented as a
plot of time against ion signal intensity; total ion mobility response or selected ion
mobility responses. Masslynx version 4.1 software (Waters corporation, Manchester,
UK) was used to control the IM-MS instrument and for data acquisition. Data mining
was carried out using DriftScope version 2 (Waters corporation, Manchester, UK).
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Results and Discussion
7-fluoro-6-hydroxy-2-methylindole (I) is converted to the O-linked indole product, 4-
[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-2-methyl-1H-indol-5-ol (II), in the presence
of air and sunlight, and through the addition of aqueous sodium hydroxide. Further
deprotonation of indole phenolate by the sodium hydroxide leads to the formation of
higher O-linked polymeric products, resulting in an increase in sample complexity
over time. The reaction was studied to provide process understanding for
pharmaceutical development. Reaction monitoring was carried out by IM-MS and MS
with electrospray ionization, to follow the rate of polymerization of the indole I to II
and other O-linked products, generating mass-to-charge and mobility data for the
analyte ions present in the reaction mixture.
NH
F
OH
NH
F
O
NH
NH
F
O
OH
NaOH
MeCN
Degradation
AZD2171 Indole
Indole O Dimer
+ trimers, tetramers....
Initial investigations were directed at the optimization of the composition of the
solvent system used to quench the aliquots of reaction mixture extracted from the
7-fluoro-6-hydroxy-2-
methylindole Indole (I)
(II)
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reaction vessel for analysis. Three solvent systems were investigated: 100 %
acetonitrile (ACN), 50/50 (v/v) ACN/water and 49.5/49.5/1 (v/v/v)
ACN/water/formic acid.  Experiments carried out in 100 % ACN, gave a low signal
response for all ions, with a total ion mobility response ion count approximately an
order of magnitude less than the 50/50 (v/v) ACN/water and ~30 times less than the
49.5/49.5/1 (v/v/v) ACN/water/formic acid solvent system, for an initial indole
concentration of 2.5 µg ml-1.  The presence of formic acid quenches the base
catalysed reaction and enhances ionization efficiency, so 49.5/49.5/1 (v/v/v)
ACN/water/formic acid was used for reaction monitoring with spectral acquisition
carried out immediately after sample dilution.
Calibration curves were created from the indole standards for both IM-MS and MS
analysis.  IM-MS analysis has a lower linear dynamic range than MS because of
detector saturation, but the analysis of the calibration standards showed a linear
response in the concentration range 0.1 - 5 µg ml-1 for the indole, with an R2 value of
0.9941.  To ensure experiments were carried out within the linear dynamic range of
the instrument, sample aliquots removed from the reaction vessel were diluted to a
concentration within the linear dynamic range for the analysis. IM-MS data were
acquired by repetitive scanning of nested data sets, with mass spectra (45 µs/scan) and
IM spectra (~13 ms) scanned repetitively throughout, spectra were accumulated to
yield 200 mass spectra and one IM spectrum every 7 seconds. The IM drift time is
plotted as ‘bins’, where each bin corresponds to an acquired mass spectrum.
The total ion and selected ion mobility responses for the IM-MS analysis of the indole
reaction mixture one hour after addition of aqueous sodium hydroxide are displayed
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in Figure 1. The selected ion response for the protonated indole, II (m/z 311.13;
Figure. 4.3(a)), shows a sharp peak, compared to the total ion mobility response,
which is centered at a drift time of 5.72 ms and has a peak width at half height of 25
bins.  The corresponding mass spectra are shown in Figure 4.4.
 The mass spectrum obtained by combining all 200 bins (Figure 4.4(a)) corresponds to
the spectrum expected in the absence of IM separation and contains a large number of
ions across the whole mass range.  In contrast, when the mass spectrum obtained in
IM-MS mode by combining bins 128-130 (drift time range 5.7-5.8 ms; Figure. 4.4(b))
is compared with the mass spectrum in the absence of ion mobility separation, the
relative intensity of the [M+H]+ ion for II (m/z 311.13) has been enhanced selectively
and is observed as the base peak in the ion mobility-selected mass spectrum.
The complexity of the reaction mixture one hour after addition of sodium hydroxide is
illustrated in Figure 3, which shows the m/z versus ion drift time (bins) space,
averaged over the whole IM-MS analysis, allowing good visualisation of the full IM-
MS analysis data. The protonated monomer (I), O-linked dimer (II) and O-linked
trimer ions are highlighted showing that these ions are resolved on the basis of mass-
to-charge and drift time. The drift time of an ion may be used to determine the
collision cross section (Ω, Eq. 1), which may be correlated with modelled or predicted
structures20-24, so IM-MS data has the potential for the structural analysis of mass-
selected transient intermediates and products in complex reaction mixtures for
enhanced process understanding.
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The indole the reaction mixture was monitored by MS and IM-MS over a period of
seven days. The reaction of indole monomer (I, m/z 166) to O-linked dimer (II, m/z
311) following addition of aqueous sodium hydroxide was fast, indicated by the
reaction mixture rapidly turning from a straw coloured to a dark brown solution. The
reaction continues via further addition of indole phenolate, with elimination of
fluorine, to produce higher polymeric products. Figure 4 displays the time dependent
ion intensities for the protonated ions derived from the reactant and products under
MS and IM-MS analysis: m/z 166 (monomer, I), m/z 311 (O-linked dimer, II),
m/z 456 (O-linked trimer), m/z 601 (O-linked tetramer), m/z 746 (O-linked pentamer)
and m/z 891 (O-linked hexamer).  Products and reactants ions were observed under
both MS and IM-MS conditions. The ion intensities were lower in IM-MS mode,
because of the transmission efficiency through the IM drift cell, but the instrumental
sensitivity was sufficient to for monitoring reaction reactant and products throughout
the course of the reaction. Ion counts were generated by combining selected bins
(mass spectra) from the ion responses for each ion of interest at half height across the
mobility peak.  The O-linked dimer formation quickly reached a maximum intensity
after the addition of sodium hydroxide and decreased thereafter as seen in Figure 4.
The decrease in dimer ion intensity was associated with further polymerisation to
form higher multimers. The formation of O-linked trimer reached a maximum at the
same time as the dimer, but ion intensity showed only a slow decline during the first
80 minutes, followed thereafter by a sharper decline. The O-linked tetramer, pentamer
and hexamer ion intensities rose more slowly, with the tetramer reaching an ion count
maximum after 60-80 minutes in both the MS and IM-MS modes.  The total ion
current for all ions summed falls with time reflecting the difference in mass
spectrometric response between the O-linked multimers and the monomer. These data
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suggest that the monomer was progressively converted to the higher oligomers over
time. The close similarity of the ion intensity trends observed in both the MS and IM-
MS modes demonstrates that no loss of information is observed in IM-MS mode,
whilst the greater selectivity and potential for structural analysis that IM measurement
brings to the analysis has the potential to enhance ion assignments and process
understanding.
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Conclusion
This study has demonstrated that ion mobility-mass spectrometry can be employed as
a rapid means to analyse a model chemical reaction mixture, offering the potential for
real time reaction monitoring. The IM-MS approach has been shown to have potential
to enhance visualization of the data selectivity for analytes compared with MS alone,
as a direct result of the orthogonal mobility and mass-to-charge separation.
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Legends to Figures
Figure 1.  Ion mobility spectra for the IM-MS analysis of 7-fluoro-6-hydroxy-2-
methylindole reaction mixture: (a) total ion mobility spectrum, (b) selected ion
mobility response for m/z 311
Figure 2.  Mass spectra for the IM-MS analysis of 7-fluoro-6-hydroxy-2-methylindole
reaction mixture: (a) mass spectrum obtained by combining all 200 bins acquired
during the ion mobility separation and (b) mass spectrum corresponding to the
selected ion response for m/z 311 (bins 128-130)
Figure 3.  2D plot of drift time (bins) vs m/z for full data set of IM-MS analysis of
indole reaction mixture, one hour after addition of aqueous sodium hydroxide, (a)
indole monomer (m/z 166, I), (b) O-linked dimer (m/z 311, II) and (c) O-linked trimer
(m/z 452).
Figure 4. MS and IM-MS analysis of the reaction of 7-fluoro-6-hydroxy-2-
methylindole following the addition of aqueous sodium hydroxide. (a) signal response
versus time in minutes for m/z 166 (monomer), m/z 311 (O-linked dimer), m/z 456
(O-linked trimer), m/z 601 (O-linked tetramer), m/z 746 (O-linked pentamer) and m/z
891 (O-linked hexamer) using (a) MS and (b) IM-MS.
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